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 Differential patterns of gene expression contribute to phenotypic 
differences between species. Understanding evolutionary changes in gene 
regulatory elements can help explain traits that separate humans from closely 
related species. Here, in two separate studies, we investigate gene expression 
and gene regulatory differences between humans our closest living evolutionary 
relatives, chimpanzees, in the context of uniquely human traits: increased 
susceptibility to epithelial cancers and neural developmental and functional 
processes that underlie our increased cognitive capacity. Using genomic 
methods to study gene expression and open chromatin, we compare human and 
chimpanzee responses to a serum challenge, an assay that that mimics patterns 
of gene expression that occur during cancer progression, and in another 
approach, we investigate the functional consequences of evolutionary changes in 
non-coding regulatory elements in neural progenitor cells and neurons. These 
studies identify recently evolved changes in physiological stress responses in 
humans, and patterns of adaptive changes in regulatory elements around highly 
conserved developmental pathways. Together, using these comparative genomic 
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studies in relevant physiological contexts, we can thus further define the 
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1.1 Genotypes and phenotypes 
 Humans and chimpanzees are closely related species and shared a 
common ancestor ~5-7 million years ago. While our genotypes are quite similar, 
our phenotypes are very different. The overall sequence divergence between our 
genomes is ~4%, with only 1.23% coming from single nucleotide substitutions 
and ~3% from insertions and deletions. Protein sequences are even more similar 
with ~29% identical sequences, and < 1% difference in amino acid sequence 
(The Chimpanzee Sequencing and Analysis Consortium 2005). However, our 
phenotypes differ in many ways. Most noticeably are differences in our anatomy, 
behavior, and cognitive capacity, but important and perhaps more subtle 
differences are in physiology and disease susceptibility (Olson and Varki 2003; 
Varki and Altheide 2005). How can genomes with a high level of similarity 
produce profoundly different phenotypes?  
1.2 Gene regulation 
 In the second half of the 20th century, efforts to study the molecular 
relationships between humans and other primates often focused on amino 
sequence comparisons of blood proteins. Those experiments showed that 
humans and other primates had identical amino sequences in proteins such as 
fibrinopeptides, cytochrome c, and several hemoglobin isoforms. (Doolittle, et al. 
1971; National Biomedical Research Foundation 1972; Boyer, et al. 1971; De 
Jong 1971). These observations inspired the seminal hypothesis by King and 
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Wilson (1975) that protein sequence changes alone were insufficient to account 
for the observed biological differences between humans and chimpanzees, and 
instead, that regulatory changes are responsible for the differences between our 
species. Indeed changes in the activity of regulatory elements have been shown 
to control differential traits between species including changes in wing 
pigmentation in fruit flies (Gompel, et al. 2005), pelvic reduction in stickelback 
(Chan, et al. 2010), and limb loss in snakes (Kvon, et al. 2016). Uncovering the 
mechanisms behind gene regulatory evolution remains a challenge, but progress 
enabled by high-throughput genomic sequencing provides powerful approaches 
to studying gene regulation. 
 The human genome is ~3.2 billion base pairs in size, and although only 
~3% of that codes for proteins, it is estimated that ~80% of the genome has 
biochemical function (ENCODE Project Consortium 2012; International Human 
Genome Sequencing Consortium 2001). Elements that control the regulation of 
gene expression largely occur in non-coding regions, and genome-wide scans for 
putative regulatory elements typically show hundreds of thousands of sites, far 
outweighing the total number of genes (ENCODE Project Consortium 2012). In 
general, the elements that control gene regulation are grouped broadly into two 
classes: cis-regulatory elements and trans-acting factors. Elements that act in 
cis- are DNA sequences that regulate transcription typically by binding 
transcription factors. Cis-regulatory elements primarily comprise promoters that 
are located immediately upstream of the genes that they regulate and bind 
general transcription factors, enhancers that act independent of distance or 
 
 3 
orientation to the genes they regulate and bind tissue or cell-type-specific 
transcription factors, and insulators that bind proteins linking them to other 
regions of the chromosome thereby establishing chromatin domain boundaries. 
Factors that act in trans- are typically proteins, transcription factors, or other 
diffusible molecules that control transcription by binding regulatory sequences or 
other proteins. An additional layer of regulation comes from the structure of 
chromatin, which can be densely packed into a transcriptionally inactive state 
called heterochromatin, or a less condensed state called euchromatin. Boundary 
sequences can separate heterochromatin from euchromatin and create loops 
that physically link distal sequences into discrete domains. The unique 
combination of cis-regulatory elements, trans-acting factors, and chromatin 
structure creates a highly complex system of gene regulation that controls when 
and where genes are expressed. 
 Patterns of gene expression are responsible for defining the identity of cell 
types (Hutchins, et al. 2017; Trapnell 2015), and changes in the regulation of 
gene expression are an important part of the evolution of development and 
shaping adaptive phenotypes (Carroll 2005; Wray, et al. 2003). Much of the 
control of gene expression is informed by the activity of enhancers that specify 
spatiotemporal patterns of gene expression (Long, et al. 2016). Enhancers 
contain specific sequences that bind transcription factors and these sequences 
work in a combinatorial way to define the activity of an enhancer (Rubinstein and 
de Souza 2013). Binding of transcription factors recruits co-regulators and the 
mediator complex that, in combination with the looped structure of chromatin, 
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affect the association of enhancers with promoters and the assembly of 
transcriptional machinery (Heinz, et al. 2015). 
 Gene regulatory networks are complex and often involve contributions 
from more than one enhancer. This modular organization of regulatory elements 
has several key features: multiple regulatory sites control transcription, the 
strength of enhancers differs within a regulatory network, enhancers can act 
redundantly, additively, or synergistically, and some enhancers work in specific 
spatiotemporal contexts to control transcription (Rubinstein and de Souza 2013). 
Studies in fruit flies and mice show that developmental enhancers often have 
redundant activity and can confer robust gene expression in spite of genetic 
variation or environmental variability (Cannavo, et al. 2016; Frankel, et al. 2010; 
Moorthy, et al. 2017; Osterwalder, et al. 2018; Wunderlich, et al. 2015). 
Redundant enhancers may provide a flexible regulatory network to allow fine-
tuning of gene expression by adaptive modification of new or weak enhancers. 
Enhancers can also work in an additive or synergistic way to control gene 
expression, but these influences are probably less common and the composite 
effects may be related to the strength individual enhancers (Ertzer, et al. 2007; 
Hay, et al. 2016). The relative contributions of enhancers can also change 
through developmental time. Lam et al. (2015) show that enhancers driving 
Pomc transcription contribute additively in adult mice and synergistically in 
embryos. The modular organization of regulatory networks is thus a critical 
component in defining the specific expression patterns of genes in different cell 
types and at different stages of development. 
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1.3 Investigating gene regulatory elements 
 Non-coding elements that regulate gene expression can be difficult to 
identify. While promoters are located immediately upstream of the genes that 
they regulate, enhancers function distally and can be located upstream or 
downstream of their target genes. Without positional information describing these 
elements, their identification relies on other experimental and computational 
methods.  
 A hallmark feature associated with active enhancers is an open chromatin 
structure that is accessible to DNA modifying enzymes such as DNaseI and 
transposase (Song and Crawford 2010; Buenrostro, et al. 2015). In contrast to 
transcriptionally inactive closed chromatin, in which DNA is tightly packaged 
around nucleosomes and condensed in heterochromatin (Felsenfeld and 
Groudine 2003), local displacement of nucleosomes allows transcription factors 
to bind DNA sequences, helping to control gene transcription (Boyle, et al. 2008; 
Thurman, et al. 2012). Genomic tools such as DNase-seq and ATAC-seq use 
these features of accessible chromatin to identify active enhancers (Song and 
Crawford 2010; Buenrostro, et al. 2015). Additionally, epigenetic modification of 
histone proteins informs about the presence of cis-regulatory sequences. In 
particular, acetylation of the 27th lysine residue on histone H3 (H3K27ac) 
distinguishes active enhancers, which when coupled with chromatin 
immunoprecipitation followed by sequencing (ChIP-seq), can identify active 
enhancers genome-wide (Creyghton, et al. 2010). 
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 In addition to experimental tools, computational methods can identify 
putatively functional non-coding elements based on sequence conservation 
among distantly related species (Nelson and Wardle 2013; Polychronopoulos, et 
al. 2017). Such sequences can remain unchanged through millions of years of 
evolution, and beyond the inference that these sequences have some functional 
role in the cell, experiments have demonstrated that many conserved non-coding 
sequences act as developmental enhancers (Aparicio, et al. 1995; Elgar 2009; 
Visel, et al. 2008).  
 Both experimental and computational approaches can identify cis-
regulatory sequences, but finding the elements that contribute to unique human 
gene regulatory programs requires further analysis. Comparative genomics 
combines these identification methods and uses direct comparison with closely 
related species to explore how evolutionary changes in regulatory sequences, or 
the activity of these sequences, differs between species. By combining 
observations about changes in gene regulatory elements with known differences 
in phenotype, comparative genomic studies can help us understand how 
changes in genotype control differential phenotypes between species. 
1.4 Thesis overview 
 The work behind this thesis aims to investigate adaptive non-coding 
changes in the human genome that contribute to differential gene expression. To 
achieve these aims we used comparative genomic approaches to study 
differences in functional non-coding elements in cultured human and chimpanzee 
cells. The first approach employed an experimental assay called a fibroblast 
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serum challenge. Fibroblasts grown in vitro and exposed to serum undergo a 
coordinated gene expression response that mimics gene expression changes 
that happen during cancer progression. Using human and chimpanzee 
fibroblasts, we characterized the global differences in gene expression and open 
chromatin between species using RNA-seq and DNase-seq. In the second 
approach, we characterized the evolution and function of human and 
chimpanzee neural enhancers with a massively parallel reporter assay. By 
testing the ability of putative regulatory elements to active transcription of a 
reporter gene in neural progenitor cells and neurons, we identified differentially 
active elements around neural and developmental pathways with putatively 
adaptive functions. Together, these assays use known physiological and genetic 
differences between humans and chimpanzees to explore the evolution of gene 
regulation. Using novel combinations of computational and experimental 
approaches we have thus broadened our understanding of the evolutionary 












COMPARATIVE SERUM CHALLENGES SHOW DIVERGENT PATTERNS OF 
GENE EXPRESSION AND OPEN CHROMATIN IN HUMAN AND 
CHIMPANZEE 
This chapter appeared as a published manuscript in 
Genome Biology and Evolution 10(3):826-839. 
2.1 Abstract 
 Humans experience higher rates of age-associated diseases than our 
closest living evolutionary relatives, chimpanzees. Environmental factors can 
explain many of these increases in disease risk, but species-specific genetic 
changes can also play a role. Alleles that confer increased disease susceptibility 
later in life can persist in a population in the absence of selective pressure if 
those changes confer positive adaptation early in life. One age-associated 
disease that disproportionately affects humans compared with chimpanzees is 
epithelial cancer. Here, we explored genetic differences between humans and 
chimpanzees in a well-defined experimental assay that mimics gene expression 
changes that happen during cancer progression: A fibroblast serum challenge. 
We used this assay with fibroblasts isolated from humans and chimpanzees to 
explore species-specific differences in gene expression and chromatin state with 
RNA-Seq and DNase-Seq. Our data reveal that human fibroblasts increase 
expression of genes associated with wound healing and cancer pathways; in 
contrast, chimpanzee gene expression changes are not concentrated around 
particular functional categories. Chromatin accessibility dramatically increases in 
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human fibroblasts, yet decreases in chimpanzee cells during the serum 
response. Many regions of opening and closing chromatin are in close proximity 
to genes encoding transcription factors or genes involved in wound healing 
processes, further supporting the link between changes in activity of regulatory 
elements and changes in gene expression. Together, these expression and open 
chromatin data show that humans and chimpanzees have dramatically different 
responses to the same physiological stressor, and how a core physiological 
process can evolve quickly over relatively short evolutionary time scales.  
2.2 Introduction  
 Deleterious genetic changes affecting traits that manifest later in life tend 
to accumulate in long-lived species. Evolutionary theory of aging explains that 
selective forces are weaker on traits that manifest later in life compared with 
those that affect survival or fecundity earlier in life (Hamilton 1966; Medawar 
1952; Williams 1957). In the absence of purifying selection, late-onset disease 
alleles can persist or accumulate in a population. Deleterious mutations affecting 
late-life traits can, however, experience positive selection if they confer positively 
adaptive changes earlier in life (Carter and Nguyen 2011; Crespi and Summers 
2006; Williams 1957). This antagonistic pleiotropic theory of aging may explain 
why humans, who have long life spans compared with other non-human 
primates, experience higher rates of diseases that manifest later in life compared 
with our closest living evolutionary relatives (Crespi 2010; Finch 2010).  
 One of the most prominent diseases of aging affecting the human 
population is epithelial cancer. In the United States, 86% of cancers are 
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diagnosed in people over 50 years of age (American Cancer Society 2016). 
There is also a striking difference in the frequency of epithelial cancer in humans 
compared with chimpanzees (Varki and Varki 2015). In modern human 
populations, epithelial cancers cause up to 20% of deaths, but in our nearest 
living relatives, chimpanzees, rates of epithelial cancers are up to 10-fold lower 
(American Cancer Society 2016; Beniashvili 1989; Hedlund et al. 2007; McClure 
1973; Parker et al. 1997; Schmidt 1975; Scott 1992; Seibold and Wolf 1973). It is 
quite clear that environmental, lifestyle, and dietary factors drive cancer risk (Wu 
et al. 2016), but genomic differences in humans as compared with other primate 
species could also play a role. Previous studies suggest that genetic changes in 
genes associated with cancer are under positive selection in humans and can 
increase aspects of fitness early in life (Crespi and Summers 2006). While 
positive selection in regulatory regions does not strictly inform expression 
differences between species on a gene-by-gene basis, there is a stronger 
correlation at the level of biological process ontology function (Babbitt et al. 
2017), and the differentially expressed genes measured there had an enrichment 
with cancer-related genes. A similar pattern was found by Nielsen et al. (2005) 
for genes showing evidence of positive selection in coding regions. Although 
cancer-related genes were identified among the top 50 genes with signs of 
positive selection, categorical enrichment for cancer genes within that set was 
not tested. Increased cancer susceptibility, therefore, may be a trait that has 
come as a tradeoff as biological processes evolved in humans. Because of the 
close evolutionary relationship between humans and chimpanzees, 
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understanding genetic differences that contribute to disease phenotypes such as 
cancer susceptibility can assist in understanding important patterns of functional 
genetic changes that occurred relatively recently during human evolution.  
 In this study, we harnessed the power of a well-established experimental 
assay that models cancer gene expression patterns, allowing us to test the 
responses of human and chimpanzee cells. When grown in culture, fibroblasts 
exposed to serum undergo a coordinated pattern of gene expression changes 
that mimics the wound healing response (Iyer et al. 1999). Tumors have been 
likened to wounds that do not heal (Dvorak 1986), and these changes in 
challenged fibroblast gene expression were then subsequently found to strongly 
correlate with gene expression data from epithelial cancer tissue (Chang et al. 
2004). Chang et al. (2005) identified a set of core serum response (CSR) genes 
that are up- or downregulated independent of the cell-cycle, and the CSR gene 
expression profile predicts a greater risk for metastasis and death for breast, 
lung, and stomach carcinomas (Chang et al. 2005). Because humans and 
chimpanzees have significantly different cancer rates, we hypothesized that the 
serum response would be significantly different between species.  
 In order to identify the genetic differences that may drive these important 
differences in disease phenotypes, we investigated global patterns of gene 
expression in serum-challenged fibroblasts from humans and chimpanzees using 
RNA-Seq. All of the genes tested in our assay were analyzed only if there were 
orthologous genes in both species (Blekhman et al. 2010). To measure dynamic 
changes in the chromatin landscape, we also sequenced open chromatin using 
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DNase-Seq (Boyle 2008; Song and Crawford 2010) from the same cell 
population. As a way to investigate biological implications of changes in gene 
expression and chromatin accessibility, we test for categorical enrichment within 
gene ontologies, KEGG pathways, and predefined gene sets that are based on 
knowledge about biological functions. This approach allows us to quantify 
enrichments based on expression differences and use statistical methods to 
identify significant changes within gene categories as compared with the 
background set of all genes measured in this study (Huang et al. 2009b; 
Subramanian et al. 2005). In our analysis, we found that human fibroblasts 
undergo distinct physiological changes in response to a serum challenge, 
including activation of genes involved in homeostasis and cell death. 
Chimpanzee fibroblasts, however, have a much less focused response, where 
many genes show differential expression without significant gene ontology 
enrichment. We also see that serum challenge elicits a general increase in 
chromatin accessibility in human cells and decreased accessibility in chimpanzee 
cells. Thus, by using this serum challenge assay in a comparative way, we have 
identified pathways that differ between species and broad differences in the 
activation state of cells in response to serum-induced cell stress. This study 
shows that by using a comparative genomic approach in a model of wound 
healing and epithelial cancer, we can gain valuable insights into how recent 
genetic adaptations contribute to differential disease phenotypes between closely 
related species.  
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2.3 Results  
2.3.1 The Serum Response in Both Human and Chimpanzee Fibroblasts Is 
Similar to the Established CSR  
 CSR genes are upregulated or downregulated upon serum challenge; 
Chang et al. (2004) used microarrays to identify a set of 512 genes they defined 
as part of the CSR. To define this response they used the assay described 
above, where fibroblasts are grown in vitro, are starved of serum for 48 h, and 
are subsequently re-exposed to normal levels of serum in the culture medium. 
The 512 CSR genes are now part of a curated data set in the MSigDB 
(Subramanian et al. 2005), which includes 212 upregulated and 209 
downregulated genes. As a first analysis of our data, we wanted to see a 
replication of this response in our cells and gene expression platform. Although 
we compare data compared across platforms, we expect to find similar patterns 
of expression. The same sets of genes were tested in both studies, and previous 
comparisons of RNA-Seq and microarray data show significant correlation of 
expression profiles between platforms (t Hoen et al. 2008; Zhao et al. 2014).  
 We measured the serum response in fibroblasts from humans (four 
biological replicates) and chimpanzees (three biological replicates), examining 
gene expression by RNA-Seq at four time points (fig. 2.1A). Of 421 CSR genes, 
324 overlapped genes in our results. Part of the reason we test a subset of these 
genes is because throughout our analysis we only compared genes that have 
clear orthologs in both humans and chimpanzees. In both species, the majority of 
CSR genes increase or decrease expression levels as expected based on the 
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work of Chang et al. (2004) (fig. 2.1B and supplementary fig. S2.2). In human 
fibroblasts, 84% and 89% of CSR-Up genes are upregulated at 12 and 24 h, 
respectively, and in chimpanzee fibroblasts, 73% and 87% are upregulated at 12 
and 24h. Similarly, 88% of CSR-Down genes are downregulated in human 
fibroblasts, and in chimpanzee fibroblasts, 90% and 84% are downregulated at 
12 and 24 h. Of the genes that increase or decrease expression as expected, 
there are comparable numbers of significant (FDR < 10%) differences over time 
in both species. These changes in expression through the time-course of the 
assay are much as expected for a core biological process. Beyond these CSR 
genes, however, we see between-species differences in functional categories of 
genes that are involved in important aspects of physiology.  
2.3.2 Wound Healing and Cancer Pathway Genes Increase Expression in 
Human, but Not Chimpanzee, Fibroblasts during the Serum Response  
 In order to explore the biology of the serum response across species, we 
tested for gene ontology enrichment categories between time points that 
characterize the serum response pathways using GSEA (supplementary table 
S2.3; Subramanian et al. 2005). Although CSR upregulated genes are 
significantly (FDR < 0.1) enriched at 12 h in both human and chimpanzee, the 
enrichment for CSR downregulated genes is only significant in chimpanzee (fig. 
2.1C and supplementary table S2.3). In human fibroblasts, however, GO cell 
adhesion, Kyoto Encyclopedia of Genes and Genomes (KEGG) focal adhesion, 
and KEGG cancer pathway genes are significantly enriched at the 12-h time 
point in human, but not in chimpanzee. These results suggest that although the 
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CSR is similar between species, there are important wound healing and cancer-
related pathways that are upregulated in human fibroblasts but not in 
chimpanzee.  
2.3.3 Human Fibroblasts Have a Coordinated Homeostasis and Cell 
Signaling Response to Serum  
 In order to understand how human and chimpanzee fibroblasts respond to 
serum on a gene-by-gene level, we next performed differential expression 
analysis between species at each time point (McCarthy et al. 2012; Robinson et 
al. 2010). This analysis shows that there are more DE genes (FDR < 10%) with 
higher expression levels in chimpanzee than human in every comparison, with an 
average of about twice as many DE genes with higher expression in chimpanzee 
(table 2.1).  
 To investigate processes that are unique to the serum response, we 
measured enrichment for BP categories (Huang et al. 2009a, 2009b) from 
differentially upregulated genes within each species, and identified the categories 
that were enriched during the serum response (T12 and T24), but not at earlier 
time points (Pre and T0). At 12 and 24h in human fibroblasts, there were 23 and 
27 BP categories, respectively, with P-values < 0.05 (supplementary table S2.4). 
Most of these processes describe homeostasis or cell signaling and protein 
modification processes. As well, several processes related to cell death, 
development or morphogenesis, and response to stimuli are enriched. At 12 and 
24h in chimpanzee fibroblasts, there were only 2 and 37 categories, respectively, 
with P-values < 0.05. The enriched processes at 12 h are cell proliferation and 
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proximal/distal pattern formation, and at 24 h the majority of processes relate to 
cell cycle and metabolic processes. The processes identified in humans describe 
a broad response to stress and stimuli and show that fibroblasts initiate 
mechanisms to cope with a changing external environment due to the presence 
of serum. On the other hand, gene expression in chimpanzee fibroblasts is not 
enriched for any one aspect of physiology related to the serum response; instead 
it is much more diffuse over biological processes. These results suggest that the 
chimpanzee cells are reacting in a less coordinated way to regulate cell state 
during times of stress.  
2.3.4 Genes with Higher Expression in Human Fibroblasts Are Enriched for 
Development, Adhesion, and Angiogenesis Categories  
 We were interested if differences in gene expression could inform about 
fundamental differences in physiology between the two species. To explore this, 
we looked for BP categories that were enriched at all time points for human or for 
chimpanzee. These common categories may represent broad biological 
processes that are uniquely elevated in one species. Genes that were more 
highly expressed in human at Pre, T0, T12, and T24 shared enrichment (P < 0.1) 
for 18 categories across time points (fig. 2.2). These include 11 human BP 
categories that represent development, morphogenesis, or differentiation, four 
categories related to locomotion or adhesion, and three categories related to 
angiogenesis and blood vessel development.  
 Molecular function enrichment of the genes in the 11 development 
categories indicates that transcription factor activity is highly enriched at each 
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time point, with P-values < 1.1 x 10-3 and at least 3.3-fold enrichment. 
Transcription factors within this set of 22 genes have normal roles in 
embryogenesis and angiogenesis during wound healing, but are often aberrantly 
regulated in cancers (Abate-Shen 2002; Gilkes et al. 2014). Angiogenesis is an 
essential process in normal wound healing that allows for the delivery of oxygen 
and nutrients to the site of injury, and plays an important role in the formation of 
new tissue (Tonnesen et al. 2000). In a similar fashion, development of new 
vasculature is essential for the continued growth of tumors and metastasis 
(Yadav et al. 2015). Together, these data show that genes with higher 
expression in human fibroblasts enrich for critical parts of the wound healing 
process at all time points.  
 Using the same between-species differential expression and biological 
process enrichment data set we looked for processes that were shared in 
chimpanzee between all time points. Here, we found no common BP categories 
with significant enrichment P-values (P < 0.1). However, in order to explore some 
categories that may be enriched in chimpanzees, we relaxed this requirement to 
categories with P-value < 0.25 and found eight categories that were shared 
between time points (fig. 2.2). Similar to our analysis of processes unique to the 
serum response, the lack of categories that are enriched across time points 
indicates that elevated gene expression in chimpanzee fibroblasts is distributed 
across many processes, as opposed to the stronger enrichments we see in the 
human gene expression data. As an exploratory analysis, we also note a few 
categories that stand under the less stringent P-value threshold applied to 
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chimpanzee enrichments. Here, DNA catabolism and fragmentation, and 
apoptotic nuclear change categories have a high fold-enrichment, between 2.9 
and 6.3, but P-values are between 0.02 and 0.2. At the 24-h time point, cellular 
component organization has a very low P-value (4 x 10-6; which accounts for the 
high standard deviation), but does not have a high fold-enrichment. Thus, while 
the error rates associated with these enrichments increase with the less stringent 
P-value applied to these data, in the absence of highly significant enrichments, 
we can nonetheless gain insight into possible biological characteristics common 
to chimpanzee fibroblasts.  
2.3.5 Genes with Signs of Positively Selected Changes in Protein Coding 
Regions Are Not Enriched among Cancer-Related Genes  
 While differences in levels of gene expression play an important role in 
controlling phenotypes (Wray et al. 2003), nucleotide level differences in protein 
coding genes within relevant disease pathways may also contribute to differential 
disease susceptibility (Puente et al. 2006). To explore genetic differences 
between species, we looked at nucleotide level differences in human and 
chimpanzee orthologs from publicly available genome sequence (Zerbino et al. 
2018).  
 We first looked at rates of nonsynonymous substitution (dN) in 973 genes 
that are important in wound healing and cancer pathways and are part of well-
defined gene sets in the MSigDB. We made estimates for each gene by selecting 
isoforms with the highest dN values. The average dN values for cancer-related 
genes and the full set of 12,865 homologues quantified in this study are 
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comparable at 0.008 and 0.0086, respectively indicating that there is no 
significant enrichment for nonsynonymous substitutions in cancer-related genes 
(two-sided Fisher’s exact test P-value = 1).  
 In order to see if there are signs of positive selection in coding regions of 
cancer-related genes, we looked at ratios of nonsynonymous to synonymous 
substitutions (dN/dS) for all genes tested in our study (supplementary table 
S2.5). Only 5.14% (50 of 973) of cancer genes have dN/dS > 1, whereas this rate 
is 7.55% (971 of 12,865) for all genes in our study (two-sided Fisher’s exact test 
P-value 1⁄4 0.00851). This lower rate suggests that there is no enrichment for 
positively selected protein coding changes in cancer-related genes as a whole. 
Nonetheless, because positively selected changes in individual genes could 
contribute to differential phenotypes, we looked more closely at which genes 
have the greatest signals of positive selection.  
 We looked in the set of cancer-related genes with dN/ dS > 1 and 
overlapped that with genes that have significantly higher expression in humans. 
In the gene coding for CXCL6, a ligand for chemotaxis and angiogenesis, dN 1= 
0.0167, which is in the 90th percentile of dN scores of all 12,865 genes in our 
study. The reported dS value is 0, preventing an exact calculation of dN/dS, but 
highlighting the excess nonsynonymous substitution rate. The genes encoding 
MXI1 and NKX3-1, both tumor suppressors, also have signatures of positive 
selection where dN = 0.0034 and 0.0053, respectively, and dS for each = 0. We 
further looked at genes with the highest dN/dS ratios to explore biological 
processes where we see strong signals of positive selection. Here, we see that 
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genes that have roles in spermatogenesis (DNAL1, TMEM225, TRIM69, 
TMCO5A), metabolism (DHRS12 and NUDT17), immune responses (IL15RA 
and TRAFD1), or apoptosis (DFFA) show the highest signals of positive selection 
(supplementary table S2.5). These data align with previous reports that these 
biological processes contain an excess number of genes with positively selected 
changes (Bustamante et al. 2005), and it is possible that genes with such 
changes could contribute to overall differences in disease susceptibility between 
species. While our data do show that there are some changes in genes that have 
possible roles in disease susceptibility, the impact of these individual changes on 
overall disease incidences is not clear. It is possible that there could be some 
protein coding changes that contribute to disease processes, but there is not a 
statistical enrichment for positively selected changes in cancer-related genes as 
a whole.  
2.3.6 Genes Upregulated in Human Fibroblasts Show Signatures of Positive 
Selection  
 Global analysis of cis-regulatory sequences within promoter regions has 
revealed evidence of positive selection in humans for genes involved in neural 
development and glucose metabolism (Haygood et al. 2007). Because we see 
particular biological processes enriched in humans at all time points and 
specifically during the serum response, we wondered if regulatory regions near 
genes that contribute to these enrichments show evidence of positive selection. 
In humans, we see that enriched biological processes are important for wound 
healing and cancer progression, and selection in non-coding regions around 
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these genes could suggest adaptation in the form of changing gene regulation. 
We compared genes identified by Haygood et al. (2007) that show signs of 
positive selection in regulatory regions with those that contribute to biological 
processes that are upregulated in human fibroblasts and found some overlap 
between the two data sets. These include MMP8, a metallopeptidase that 
contributes to extracellular matrix remodeling, NAALAD2, a peptidase that 
hydrolyses N-acetyl-aspartyl glutamate and glutamate and a marker of prostatic 
carcinomas, and ACVRL1, a receptor for TGF-β family of ligands. Outside of 
those that contribute to enriched processes are genes that are elevated in human 
fibroblasts at all time points. These include ALS2CL, RGS20, and SNX16 
involved in cell signaling, DPT, which has a role in cellular adhesion, and 
PFKFB3 involved in the control of glycolysis. These results suggest that while 
there are individual genes that are significantly upregulated in human fibroblasts 
that have signs of positive selection, these are not focused on any one biological 
process. Selection around these genes, however, does show that there are 
changes in processes important for fibroblast function, wound healing, and 
cancer progression. Because chronic wound healing processes are co-opted by 
developing tumors, adaptation for higher expression within these processes in 
humans could help explain increased disease susceptibility.  
 To look more closely at how positive selection may be shaping gene 
expression in humans, we used methods adapted from Haygood et al. (2007) to 
test for signs of selection in promoter regions of genes in our study. We used a 
set of 5,137 genes that have orthologs in human, chimpanzee, and rhesus 
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macaque and compared substitution rates in promoters to intronic sequence, 
which serves as a measure of neutral substitution rates. Here, we see 3.5% of 
promoters have signs of positive selection indicating that these events are 
relatively rare in humans (likelihood ratio test P-value < 0.01). To find out where 
these selection events are happening, we performed an enrichment analysis for 
GO biological processes. Among the most enriched processes are those related 
to neural function including anion transport, sensory perception of light stimulus, 
and visual perception, which is in agreement with the Haygood et al. (2007) 
findings that neural genes have experienced recent positive selection in proximal 
regulatory regions (supplementary table S2.6). Genes contributing to these 
enrichment include GLRA1, which mediates central nervous system post-
synaptic inhibition, FAM161A, involved in retinal progenitor cell proliferation, 
NDP, involved in retinal vascularization, and CNGA1, which is involved in 
phototransduction. Also included are transcriptional regulators MAP2K6 that 
regulates stress induced cell cycle arrest, transcription activation, and apoptosis, 
and POU6F2 which is a tumor suppressor involved in nephroblastoma 
predisposition (Di Renzo et al. 2006). While signs of positive selection do not fully 
explain differential gene expression in humans, our results here do agree with 
previous reports that neural-related processes and control of transcription are 
enriched for signs of positive selection. While we are beginning understand how 
individual genes can show positively adaptive function and also contribute to 
disease processes (Crespi and Summers 2006), we understand less about how 
adaptation and antagonism occur broadly across functional biological process 
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categories. Nonetheless, signs of adaptation around individual genes can offer 
some insight into how physiological responses change over evolutionary time.  
2.3.7 Human Chromatin Has Significantly More Open Chromatin than 
Chimpanzee  
 Layering in a second data set, we examined global changes in chromatin 
accessibility over the challenge time points using DNase-Seq (Boyle 2008). 
Regions of open chromatin are susceptible to DNaseI cleavage (Keene et al. 
1981) and sites hypersensitive to DNaseI mark many types of regulatory 
elements (Gross and Garrard 1988). As a preliminary characterization, we looked 
to see if the locations of our DHS sites have been identified in previous studies 
that used DNase-Seq, we scanned for the presence of transcription factor 
binding motifs, and looked at how openness of DHS sites changes relative to 
proximity to transcription start sites (supplementary text). Together, these 
characteristics suggest that the DHS sites we identified contain functional 
elements and help to validate our DNase-Seq data set.  
 In order to compare the activity of DHS sites between species, we used a 
5% FDR to identify significant differences at each time point. There are ~9,000–
10,000 sites with significantly different DHS signals at every time (fig. 2.3A). 
Importantly, not all DHS sites are present in both human and chimpanzee 
fibroblasts. To more deeply investigate how chromatin changes during our assay, 
we identified sites that were shared between species, and those that are species-
specific. Many of the significant differences in DHS signal are, appropriately, in 
species-specific DHS sites. However, of the sites that are shared between 
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species, there are significantly (Fisher’s exact test P-value < 2.196 x 10-9) more 
sites with higher DNaseI sensitivity in human at all time points. During the serum 
challenge, chromatin containing DHS sites shared between species increases 
accessibility in human fibroblasts and decreases in chimpanzee. This, along with 
the larger number of human-specific sites indicates greater chromatin 
accessibility in general (Pre and T0), and in response to stress (T12 and T24) in 
human fibroblasts.  
 Not all of the DHS sites identified are active at all time points. In terms of 
percentage of active sites at any given time point, more shared sites are active 
than species-specific sites (fig. 2.3B). Interestingly, even though humans have 
twice as many active species-specific sites as chimpanzee (fig. 2.3C), the 
percentage of these sites that are active through the assay is comparable (fig. 
2.3B), suggesting that technical differences in genome annotation are not 
responsible for higher levels of species-specific DHS sites in human. While the 
total number of active DHS sites in human fibroblasts remains relatively stable, 
chimpanzee chromatin shows a decrease in accessibility during the first 12 h of 
the serum challenge, particularly at shared DHS sites (fig. 2.3C). These data 
suggest that chimpanzee chromatin responds to the stress of the serum 
challenge with a general decrease in accessibility.  
2.3.8 DHS Sites That Cluster in Patterns of Opening and Closing Chromatin 
Reflect Functional Control of Transcription and Adhesion Processes  
 In order to explore temporal patterns of chromatin state, we performed 
fuzzy clustering (Futschik and Carlisle 2005) of the mean -10log10 P-values of 
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DHS sites within each species during the serum challenge. Most clusters have a 
bimodal shape, which generally describes a site as open or closed at a given 
time point. Interestingly, the top three cluster shapes with the highest 
membership values are the same in both human and chimp (supplementary fig. 
S2.5). There are particular clusters that are interesting in terms of activity, 
specifically in response to the serum challenge. These represent DHS sites in 
which changes in chromatin openness occur: At the beginning of the challenge 
and persist, at the end of the challenge, or at the beginning of the challenge that 
revert (fig. 2.4A and B). In general, there are multiple DHS sites in proximity to 
each gene. While there appear to be comparable numbers of DHS sites opening 
and closing during the serum challenge in chimpanzee, there are ~4.5x as many 
(19,974/4,462) DHS sites in human that fit in clusters representing chromatin 
opening compared with clusters representing chromatin closing (table 2.2). 
These 4,462 DHS sites that represent chromatin closing are found in proximity to 
3,163 genes. Thus, when DHS sites are closing in human fibroblasts, there is 
frequently only about one site that closes per gene, whereas in chimpanzee there 
are ~2 sites that close per gene. When DHS sites are opening in human there 
are 2.74 sites per gene, and in chimpanzee, there are 2.25 sites per gene. Not 
only are there a larger absolute number of sites of opening chromatin in human, 
these sites are more concentrated around genes than they are in chimpanzee, 
and the change to a closed state in DHS sites in human is less concentrated 
around genes than in chimpanzee.  
 As a way to investigate the biological processes that may be controlled by 
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these regions of opening or closing chromatin, we performed gene ontology 
enrichment analysis (Eden et al. 2009) of genes closest to DHS sites belonging 
to clusters that represent chromatin opening or closing during the serum 
challenge. Among the enriched categories, particular processes were common 
between species. We computationally grouped these processes into 
representative categories using key terms (fig. 2.4C and D). For example, the 
“Development” category represents biological processes of development, 
morphogenesis, and differentiation, and the “Growth” category represents 
processes of growth, proliferation, death, and apoptosis. All processes were 
enriched with P-values < 10-3. Grouping these categories shows common themes 
among the enrichments and shows similar themes to gene expression 
enrichments. Development categories are among the most prevalent, and similar 
to gene expression enrichments, transcription factor activity is one of the most 
highly enriched molecular functions from these genes. In agreement with gene 
expression enrichments, motility, adhesion, migration, and growth, death, 
apoptosis, and proliferation are enriched in up- and downregulated clusters. 
Although there are a small number of categories related to wound healing, it 
seems this response is more highly enriched in chimpanzee than human.  
2.3.9 Positive Correlations Exist between DHS Sites and Levels of Gene 
Expression  
 Next, we wanted to bring our two data sets (RNA-Seq and DNase-Seq) 
together to examine how DHS activity and distribution compares with expression. 
Linking gene regulation and gene expression at a whole-genome level is 
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notoriously difficult because regulatory elements can act at large distances from, 
and independent of orientation to, target genes. In the absence of annotated 
relationships between regulatory elements and target genes, linking putative 
regulatory elements and genes based on proximity is the most feasible route to 
explore these relationships on a genome-wide scale. Boyle (2008) have shown 
that there is a low correlation when directly comparing expression and the degree 
of hypersensitivity, but there is a significant difference between DNaseI sensitivity 
at the TSS of low or no expression compared with genes with moderate or high 
expression. Additionally, they show that many of the most active DHS sites are in 
promoters and within the first exon.  
 To look at relationships between DHS signal and gene expression, we 
calculated the total DHS signal for all DHS sites closest to all TSSs, and 
performed a Spearman’s correlation test against gene expression values for 
these genes. In both human and chimpanzee at each time point, Spearman’s rho 
was between 0.24 and 0.25, indicating that there is a weak but positive 
correlation between DHS activity and gene expression (supplementary fig. S2.6). 
There is a stronger correlation, however, between log2 fold-change in gene 
expression between species and the ratio of active DHS sites per gene. At each 
time point, the Spearman’s rho is between 0.327 and 0.487 and P-value is < 
2.2e-16. These data show that positive relationships exist between DHS activity 
and gene expression based on proximity of DHS sites and TSSs, but individual 
metrics describing DHS activity are not strong predictors of gene expression at 
the closest TSS.  
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2.4 Discussion  
 In response to a serum challenge, fibroblasts undergo a defined 
transcription activation profile that mimics the wound healing response (Chang et 
al. 2004) and is similar to the expression profile found in tumors (Chang et al. 
2005). In our experiments, we found a gene expression profile in both species 
that mimics the CSR described by Chang et al. (2005). There are differences in 
the response; however, and some of these may be explained by updated gene 
models and differences in experimental platforms between the studies, changing 
from microarrays to RNA-Seq. By using this assay in two closely related species 
with prominent phenotypic differences in wound healing and cancer rates, we are 
able to investigate genetic differences during the serum response in this 
physiologically relevant cell type that have evolved over a relatively short 
timescale (~5–7 million years; Chen and Li 2001; Langergraber et al. 2012).  
 Focusing on gene expression, our RNA-Seq data suggest that the CSR is 
similar between species; yet, there are important wound healing and cancer-
related pathways that are upregulated in human fibroblasts but not in 
chimpanzee. While chimpanzees have more genes with higher levels of 
expression than humans, these are unfocused and not enriched for specific 
biological processes. Humans, on the other hand, have fewer genes with higher 
levels of expression than chimpanzee, but these are contained within particular 
biological processes and pathways. Genes encoding transcription factors enrich 
process of development, morphogenesis, or differentiation in human fibroblasts. 
Cell adhesion processes are also enriched in humans at all time points. This 
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difference has been identified previously in gene expression and cellular focal 
adhesion comparisons in human and chimpanzee fibroblasts (Advani et al. 
2016). These molecules play critical roles in the function of fibroblasts by 
mediating cell– cell and cell–matrix interactions and have important roles in cell 
responses to external stimuli (Calvo et al. 2013; Clayton et al. 1998).  
 To look at how genetic differences between species could be affecting 
phenotypes, we looked at how protein coding regions and gene promoters differ 
between species. We found signs of positive selection in protein coding genes 
that are part of cancer-related pathways, but no enrichment among those 
processes. Some genes that are differentially expressed in humans have signs of 
positive selection and are part of cancer pathways, but a direct relationship 
between genetic changes and species phenotypes is difficult to make. Likewise, 
our analysis of positive selection in promoter regions found enrichments for 
neural-related processes, but these events are rare, only occurring in ~3.5% of 
the promoters tested. Here, we found that promoters with signs of positive 
selection have roles in neural function including visual system development and 
differentiation, and anion transport. These positively selected changes agree with 
known differences in species biology, but do not fully explain how selection in up-
stream regulatory regions contributes to gene expression.  
 The expression level of any gene is dictated by the activity of regulatory 
elements that promote or repress transcription. However, the relationship 
between number, location, and activity of cis-regulatory elements and associated 
genes globally is not clear. Because we know that DHS sites mark regulatory 
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elements, we can still, however, identify differences in availability of putative 
regulatory elements available to cells at each time point. Our DNase-Seq data 
show that human cells have higher levels of chromatin accessibility at all time 
points. The increased chromatin openness is somewhat counterintuitive 
considering the higher levels of gene expression seen in chimpanzee. One would 
expect that increased chromatin accessibility in human fibroblasts would result in 
higher levels of gene expression, but this is not the case. This may indicate that 
human cells exist in a more poised, or transcription-ready, state than chimpanzee 
cells. Open chromatin data showing a higher level of chromatin accessibility, and 
expression data showing significant changes in transcription factor activity, 
together suggest that human cells maintain a transcription-ready state, which 
could allow for a faster transcriptional response.  
 Understanding how these regions of open chromatin might be driving 
changes in gene expression remains a challenge. Because regulatory elements 
can act at large distances relative to their target genes, linking gene expression 
and regulation is difficult. Between our open chromatin and gene expression data 
sets, we only found weakly positive correlations based on sequence proximity. 
To identify specific links between regulatory elements and a specific gene 
expression level will require more targeted experiments, such as luciferase 
assays.  
 Comparative approaches to studying genomic differences between 
species make extensions of our knowledge of biology across species. Although 
some assumptions are made about functional conservation, genetic differences 
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between species correlate with known differences in species biology. In taking a 
comparative approach to investigating genomic responses to a well-defined 
experimental assay in two closely related species, we begin to explore how 
genetic changes functionally contribute to differences in a core physiological 
process over a relatively short evolutionary time scale. Here, we see that humans 
and chimpanzees have very different responses to the same physiological 
stressor. The human response is generally rapid and robust with focused 
changes in gene expression and chromatin openness around functional groups 
of genes important for wound healing. This response may be part of a genetic 
adaptation that allows for quick mobilization of transcriptional programs to cope 
with changing extracellular state. The ability to quickly engage robust genetic 
responses to a wound healing stimulus or respond to other stimuli could have 
important adaptive function (de Nadal et al. 2011; Lopez-Maury et al. 2008). 
However, a strong or prolonged wound healing response in the context of a 
cancerous lesion could be deleterious. While this experimental assay does not 
describe mechanisms that initiate disease, it does serve as a way to explore how 
genetic programs that significantly differ between humans and chimpanzees 
could contribute to increased disease susceptibility in humans.  
 Striking differences in the rates of epithelial cancers exist between 
humans and chimpanzees. The lifetime risk for development of cancer depends 
on the effects of acute and cumulative exposure to environmental factors, but 
also on genetic defects and predisposition (American Cancer Society 2016; 
Lichtenstein et al. 2000; Stearns and Medzhitov 2016). Certain environmental 
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factors play a large role in human exposure (American Cancer Society 2016) but 
not in chimpanzees, while exposure to carcinogens through other environmental 
factors may be more similar between species (Varki and Varki 2015). While part 
of the difference in cancer rates between our species is due to these external 
factors, genetic differences likely play a role as well. Comparative genomics 
allows for investigation of global differences in gene expression and chromatin 
responses between humans and chimpanzees. This approach can identify 
genetic changes that occurred as humans diverged from the most recent 
human–chimpanzee ancestor, which may be responsible for particular 
phenotypes (Olson and Varki 2003), and which may be driven by differential 
gene expression rather than changes in protein coding regions (reviewed in 
Carroll 2005; Wray et al. 2003). Changes in the activity of regulatory elements 
can offer a mechanistic explanation for differential expression between species. 
These changes can occur rapidly over evolutionary time, such as the ~5–7 mya 
divergence measured here, possibly driven by positive selection giving rise to 
new phenotypes. Along with positive adaptations, however, can come side 
effects that manifest later in life-history as unfavorable phenotypes such as 
disease susceptibilities. These unintended changes might not be readily visible to 
selection and may be propagated over evolutionary time. The use of evolutionary 
comparisons to better understand shifting rates of disease between humans and 
nonhuman primates can be used as a valuable tool for studying genetic factors 
that confer uniquely human characteristics and disease susceptibilities.  
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2.5 Materials and Methods  
2.5.1 Serum Challenge  
 Fibroblast cell lines were obtained from the Coriell Institute for Medical 
Research (Camden, NJ) from four male humans and chimpanzees (Pan 
troglodytes; supplementary table S2.1). Our cell culture methods approximately 
followed those of Chang et al. (2004) and Iyer et al. (1999). Briefly, we seeded 
cells in media with FBS (Hyclone defined FBS (-)HI, Fisher) at ~50% confluency 
and grew overnight. At 60% confluency one set of plates were set aside and 
processed as described below (fig. 2.1A, “Pre-challenge” time point). The 
remainder of the cells were then incubated in starvation media (0.1% FBS) for 48 
h, after which the growth media was replaced. Collections were then done at time 
0, 12 h, and 24 h. All cells for the RNA-Seq and DNase-Seq experiments were 
from the same batch and collected at the same time. For the RNA-Seq assays, 
cells were rinsed with Qiazol (Qiagen) and vortexed. The RNA was isolated using 
an RNeasy kit (Qiagen), with a DNaseI treatment. For the DNase-Seq assays, 
~20 million cells were spun down and slowly frozen in freezing media (Gibco) to -
80°C.  
2.5.2 RNA-Seq Library Preparation  
 NGS libraries were prepared using the NEB RNA-Seq library kit for 
Illumina, and sequenced on a HiSeq at Duke University Genomics Core. 
Sequences were mapped to the species-specific genome (hg19 and panTro3) 
using Tophat v.1.4.1 (Trapnell et al. 2009). Counts per gene were determined 
using HT-Seq (Anders et al. 2015) for genes with clear orthologs in human and 
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chimpanzee (Blekhman et al. 2010). The data were normalized using edgeR 
(Robinson et al. 2010) with a GLM for multifactor experiments (McCarthy et al. 
2012), so that all time point expression was normalized under one model, unless 
specific time points are mentioned. 199 clones representing 165 genes that were 
previously identified as being “cell cycle” genes that change through the cell 
cycle regardless of the serum challenge were removed (Chang et al. 2004; 
Whitfield et al. 2002).  
2.5.3 DNase-Seq Library Preparation  
 Library preparation was performed as in Song and Crawford (2010), and 
sequencing was performed on a HiSeq at Duke University Genomics Core. 
Sequences were trimmed to 20mer lengths and barcodes removed. In order to 
compare DHS sites between species, we Bowtie-mapped (Langmead et al. 
2009) reads to appropriate genomes and brought chimpanzee coordinates to 
human space using liftOver (Hinrichs et al. 2006). We called peaks with MACS 
(Zhang et al. 2008) using a lower P-value threshold of 1e-5 and found an 
average of ~150,000 peaks in human samples, and ~116,000 peaks in 
chimpanzee samples. We counted sites as active if there was a DHS signal in at 
least 1 replicate. To compare chromatin DNaseI sensitivity at corresponding 
locations between samples, we defined windows by intersecting DHS sites 
across all species using BEDTools (Quinlan and Hall 2010). Our approach to 
defining DHS sites between replicates and between species by using shared 
“windows” is also graphically explained in the supplementary material 
(supplementary fig. S2.1). This gave 379,723 windows between human and 
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chimpanzee samples. We filtered windows to exclude those <50 bp or >2,000 bp, 
which gave 264,091 sites. The windows from our study include DHS sites that 
are shared between species, and those that are species-specific. 125,411 sites 
were shared, 95,983 were human-specific, and only 42,697 were chimpanzee-
specific. In any given sample newly defined windows may cover zero or multiple 
DHS sites. To assign values to each new set of coordinates in each sample, we 
chose the DHS site with the lowest P-value as representative of the activity within 
each window.  
2.5.4 DHS Window Overlap with ENCODE Data  
 Data were downloaded from ENCODE that were generated in DNase-Seq 
experiments in human fibroblasts, cancer cell lines, hepatocytes, pancreas, or 
cerebellum tissues (supplementary table S2.2). Additionally, DNase-Seq data 
from human fibroblasts and LCL cells (Shibata et al. 2012) were used in our 
fibroblast comparison. Subsets of our DHS sites were selected to test for overlap 
with external data. Windows were first screened for size and only those between 
50 bp and 2 kb were selected. Additionally, a set of “human windows” was 
selected by removing DHS sites from the 50 bp–2 kb set that did not show any 
DHS signal at any time point in any human sample. Overlap between our DHS 
sites and external data was measured using BEDTools (Quinlan and Hall 2010). 
The exact command used to test for overlap was: Bedtools intersect -u -a 
OurWindows -b ENCODE_XX_Windows > XX_overlap.  
2.5.5 Gene Set Enrichment Analysis  
 We tested for enrichment of 12 gene sets downloaded from the Molecular 
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Signatures Database (MSigDB) using the Gene Set Enrichment Analysis (GSEA) 
desktop graphical user interface (Subramanian et al. 2005). GSEA tests if a 
predefined set of genes has a statistically significant association with one of two 
biological states (time points in our assay). We used this analysis to test for 
enrichment of GO and KEGG gene sets associated with cancer pathways, 
wound healing, cell adhesion, and for CSR genes. Data in the form of raw read 
counts were input to test for enrichment between time points during the first 12 or 
24 h of the serum response. A rank-ordered list of genes that are statistically 
different between time points is created, and the positions of a predefined set of 
genes are determined within this list. An enrichment score is calculated based on 
a running-sum statistic that increases when a gene is present in the rank-ordered 
list and decreases when it is not.  
2.5.6 Estimation of Differential Expression  
 We used edgeR (McCarthy et al. 2012; Robinson et al. 2010) to perform 
differential expression analysis on RNA-seq and DNase-Seq data sets. Briefly, 
edgeR fits read counts to a negative binomial generalized linear model and 
performs a likelihood ratio test to identify differences between groups. We 
performed this analysis between time points within species to characterize genes 
that change expression and DHS sites that change activity during the serum 
response. To characterize between species differences, we performed the 
analysis at each time point between human and chimpanzee.  
2.5.7 DAVID Enrichment Analysis  
 We performed differential expression analysis between human and 
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chimpanzee at each of four time points in our experiment. Genes that were 
significantly (FDR < 0.1) upregulated in each species were selected for 
enrichment analysis. We sought to investigate enrichments within differentially 
expressed genes in comparison to a background set of genes expressed in 
fibroblasts. Thus, we used the Database for Annotation, Visualization and 
Integrated Discovery DAVID (Huang et al. 2009a, 2009b), which tests for 
enrichment in the context of a user-defined background. DE gene IDs were 
supplied to DAVID and the set of all genes active in human and chimpanzee 
fibroblasts was used as the background. We tested for enrichment using GO 
biological process annotations for our DE genes and molecular function of 
subsets of differentially expressed genes within particular biological process 
categories. For analysis of human enrichments, categories with P-values<0.1 
were characterized, whereas for chimpanzee enrichments, we explored 
categories with P-values < 0.25. This less stringent threshold was used for 
chimpanzee due to the low numbers of categories with significant enrichment 
values.  
2.5.8 Species-Specific and Serum-Response-Specific Enrichments  
 In order to determine which categories were enriched at every time point 
for a particular species, we performed enrichment analysis using DAVID (Huang 
et al. 2009a, 2009b). Category lists were read into R and were intersected to 
identify categories that were present in all time points for either human or 
chimpanzee. To identify BP categories that were enriched during the serum 
response but not before, for both human and chimpanzee, we read category lists 
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into R, obtained union sets for the Pre and 0 h time points (early set), and then 
found the set differences between the 12 or 24 h enriched categories and the 
early set.  
2.5.9 Analysis of Positive Selection in Genes and Promoters  
 We tested for signs of positive selection in protein coding regions of genes 
by comparing rates of nonsynonymous and synonymous substitutions (dN/dS). 
Data were collected from Ensembl for 12,865 human protein-coding genes and 
their homologs in chimpanzee (Zerbino et al. 2018). We also looked at dN/dS for 
973 genes that are part of relevant cancer-related categories (Core Serum 
Response, GO Cell Matrix Adhesion, GO Extracellular Matrix, GO Regulation of 
Cell Adhesion, GO Response to Wounding, GO Wound Healing, KEGG Basal 
Cell Carcinoma, KEGG, Cell Adhesion Molecules, KEGG Focal Adhesion, KEGG 
Pathways in Cancer, Mishra Carcinoma Associated Fibroblast UP). Gene lists 
were collected from the MSigDB (Subramanian et al. 2005).  
 Additionally, we looked for signs of positive selection in human promoter 
sequences (5kb regions upstream of transcription start sites) using code from 
Haygood et al. (2007) available on GitHub (https://github.com/ofedrigo/ 
TestForPositiveSelection) for 5,137 genes with clear orthology in chimpanzee 
and rhesus macaque (Macaca mulatta), which we use as an outgroup in this 
analysis. Briefly, this code runs using HyPhy software (Pond et al. 2005), and 
calculates nucleotide substitution rates in promoter sequences and compares 
this to neutral substitution rates in nearby intronic regions (first intron of a genes 
were excluded). P-values were used to identify promoters with significantly 
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higher rates of substitution on the human branch.  
2.5.10 Identifying Putative Transcription Factor Binding Sites Using 
JASPAR  
 In order to identify known transcription factor binding motifs that are 
contained within our DHS sites, we collected hg19 sequences corresponding to 
our DHS coordinates and scanned these sequences for known motifs that are 
described in the JASPAR database (Sandelin et al. 2004). We searched for all 
Homo sapiens motifs on both + and - strands and specified a minimum score of 
100% using R packages TFBSTools (Tan and Lenhard 2016) and JASPAR2016 
(Mathelier et al. 2016).  
2.5.11 Fuzzy Clustering Analysis  
 We performed soft clustering of DHS data using mFuzz (Futschik and 
Carlisle 2005), using standardized expression sets prepared from log2 values of 
mean DHS activity among replicates for shared or species-specific DHS sites. 
The fuzzifier for each expression set was selected with the mestimate function. 
Minimum centroid distances were calculated for a range of cluster numbers using 
Dmin, and an optimal number of clusters was chosen to select the lowest 
centroid distance with the lowest number of clusters. For clusters that represent 
increases or decreases in DHS activity during the serum response, we selected 
DHS sites within each cluster with a minimum membership value of 0.6, and 
identified genes closest to each DHS site using UCSC (Karolchik et al. 2004) 
gene coordinates for genes with clear orthologs in human and chimpanzee 
(Blekhman et al. 2010). We tested for biological process category enrichment 
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from these genes with GOrilla (Eden et al. 2009), which allows testing large data 
sets against a background. The set of all genes active in human and chimpanzee 
fibroblasts was used as the background.  
2.6 Acknowledgments  
 This work was supported by a National Science Foundation Grant (NSF-
BCS-08-27552 HOMINID) to G.A.W. (https:// www.nsf.gov). The authors thank all 
the members of our research groups for valuable discussions of these studies. 
We thank Lisa Pfefferle for her extensive insight into the experimental design, 
and Trisha Zintel and Norman A. Johnson for helpful suggestions and advice 
during data analysis.  
2.7 Author Contributions  
 C.C.B., J.P., and G.A.W. were responsible for conceptualizing the study. 
W.J.N., Y.S., and A.S. performed the molecular lab work. J.P. performed the 
formal analyses. G.E.C., G.A.W., and C.C.B. provided resources and supervised 
the work. J.P. wrote the paper. C.C.B., Y.S., and G.A.W. reviewed and edited the 














Table 2.1. Differential gene expression between species at each time point 
(FDR 10%) 
Table 2.1. Differential gene xpression between species at ach time point (FDR 10%)
Pre T0 T12 T24
Higher in Human 910 925 983 856
Higher in Chimpanzee 1460 2203 1431 2350
Total DE genes 2370 3128 2414 3206
Ratio Chimpanzee DE : Human DE 1.60 2.38 1.46 2.75
Number of DE genes (FDR 10%)
Human Chimpanzee Human Chimpanzee
Number DHSs 19,974 13,282 4,462 13,350
Number Genes 7,286 5,910 3,163 6,501
ratio DHSs/ Gene 2.74 2.25 1.41 2.05
Table 2.2. DHS sites and genes associated with clusters representing opening 
and closing chromatin during the serum challenge.






Figure 2.1. Characterization of the serum response in human and chimpanzee 
fibroblasts. (A) Overview of experimental procedure. (B) Log2 fold-change in 
gene expression versus P-value of CSR genes between T0 and T12. Positive 
log2 fold-change indicates higher level of gene expression at T12. Solid blue 
line indicates P-value 0.1. Points are CSR downregulated (red) and 
upregulated (blue) genes. (C) Plots of enrichment scores and distribution of a 
priori gene sets within the expression set, rank-ordered by differential 
expression between T0 and T12. Red bars below plots indicate clusters of 
downregulated CSR genes at the bottom of the ranked list. Inset values are 





Figure 2.2. Common GO terms across time points. GO BP categories 
significantly higher in human and chimpanzee at all time points. Bars 
represent mean values across 4 time points for ln P-value (below axis) and 
fold-enrichment (above axis). Colors group similar biological processes and 
vertical lines represent 1 standard deviation from the mean.  
 
Figure 2.3. Differential chromatin accessibility in human and chimpanzee 
fibroblasts. (A) Differential chromatin DNaseI hypersensitivity was determined 
using a 5% FDR from a likelihood ratio test. (B) and (C) Active DHS sites are 
locations in which a DNaseI signal with a P-value of at least 1e-5 is present in 
at least one replicate. Red lines with filled markers represent activity of 
human-specific DHS sites. Blue lines with filled markers represent activity of 
chimpanzee- specific DHS sites. Red lines with empty markers represent 
activity of shared DHS sites in human fibroblasts. Blue lines with empty 











Figure 2.4. Fuzzy clustering and ontology enrichments. Clusters represent 
either an (A) increase or (B) decrease in chromatin accessibility following 
serum replacement. (C) and (D) Common GO terms generated from genes 
nearest DHS sites belonging to clusters that indicate (C) increasing or (D) 




FUNCTIONAL ANALYSIS OF HUMAN AND CHIMPANZEE NEURAL 
ENHANCERS WITH A MASSIVELY PARALLEL REPORTER ASSAY 
3.1 Abstract 
 Understanding the molecular processes that underlie human phenotypes 
is one of the great challenges in modern biology. Comparative genomic studies 
with our closest living evolutionary relatives, chimpanzees, show a high level of 
sequence similarity between our species implicating differential gene regulation 
as an important mechanism contributing to phenotypic divergence. Changes in 
non-coding regulatory elements are associated with differential traits between 
species, and non-coding sequence variants are associated with human 
phenotypic variation in health and disease. Sequences of DNA with putative 
regulatory function called cis-regulatory elements (CREs) can be identified by 
computational or experimental methods, and although we can identify these 
regions computationally, their functions are poorly characterized. In this study we 
selected human and chimpanzee CREs for functional testing with signs of 
accelerated evolution in humans or that are active in human brain development. 
Using a lentiviral-based massively parallel reporter assay (MPRA), we tested the 
ability of orthologous human and chimpanzee CREs to activate transcription in 
iPSC-derived neural progenitor cells and neurons. With this assay we identified 
179 CREs with differential activity between human and chimpanzee orthologs 
and 722 CREs with signs of positive selection in humans. Selection and DE 
CREs differ in level of expression, size, and genomic location. We found a subset 
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of 69 CREs in loci with genetic variants associated with neuropsychiatric 
diseases, which underscores the consequence of regulatory activity in these loci 
for proper neural development and function. Unexpectedly, we also found an 
abundance of CREs with signs of positive selection or differential expression 
around genes that modulate the Wnt signaling pathway. Together, this analysis 
of transcriptional activity and selection in CREs uncovers putatively adaptive 
changes in gene regulation contributing to human specific neural phenotypes. 
3.2 Introduction 
 Changes in the regulation of gene expression underlie phenotypic 
differences between species and individuals within a species. It was 
hypothesized by King and Wilson (1975) that phenotypic differences between 
humans and chimpanzees were due to differences in gene expression, rather 
than protein coding changes. Since then, changes in the regulatory elements 
have been shown to control differential traits between species including changes 
in wing pigmentation in fruit flies (Gompel, et al. 2005), pelvic reduction in 
stickelback (Chan, et al. 2010), and limb loss in snakes (Kvon, et al. 2016). 
Furthermore, non-coding regulatory variants in the human population are 
associated with differences in disease susceptibility between individuals 
(ENCODE Project Consortium 2012; Pai, et al. 2015; Schaub, et al. 2012). 
Sometimes individual genetic polymorphisms are sufficient to drive phenotypes, 
but in many cases traits are polygenic and multiple loci contribute to traits (Boyle, 
et al. 2017; Kathiresan, et al. 2009). In other cases the presence of deleterious 
alleles alone are insufficient to manifest differential phenotypes, but rely on 
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combination with other alleles or external factors before differential traits emerge 
(Cooper, et al. 2013). Non-coding changes that give rise to phenotypic 
differences between humans and chimpanzees therefore may also contribute to 
differential phenotypes within the human population if other genomic variants 
interact. Understanding where non-coding genetic variants occur, and their 
impacts on regulatory function, are critical to understanding how traits arise 
between species and how those changes contribute to differential phenotypes 
between humans. 
 Regulation of transcription occurs through the interaction of cis- and trans- 
factors that help assemble transcriptional machinery at gene promoters to active 
transcription (Allen and Taatjes 2015; Heinz, et al. 2015). Cis-regulatory 
elements (CREs) are non-coding sequences that bind transcription factors and 
can activate transcription of genes, and trans-factors are the products of genes 
that regulate gene expression through interactions with DNA or other proteins. 
Enhancers are a class of CREs that function independent of distance or 
orientation to their target genes and help modulate transcription in specific ways. 
Elaboration of transcription profiles can change in spatiotemporal ways through 
the modification of enhancers of that introduce new patterns of gene expression 
(Koshikawa, et al. 2015; Rebeiz, et al. 2011). Most enhancers are located in 
introns of genes and intergenic regions and enhancers have been reported that 
are located up to 1 Mb from their target gene (Lettice, et al. 2003). Trans-factors 
on the other hand are typically proteins, such as transcription factors, that bind 
CREs to activate transcription, but can include any diffusible molecule, such as 
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non-coding RNA, that can influence gene expression. While interactions between 
cis- and trans- factors are required for defining the transcriptional activity of a 
regulatory sequence, much of the specific control of transcription comes from 
enhancers that specify when and where genes are expressed (Long, et al. 2016), 
which makes characterization of these elements an important part of 
understanding the regulation of gene expression. 
Putative non-coding regulatory sequences can be identified by 
computational or experimental methods. Computational methods are often 
focused on identifying conserved non-coding sequences (CNSs) that have 
experienced minimal change through millions of years of evolution. Because of 
this evolutionary constraint, functionality is assumed, and indeed many of these 
have demonstrated enhancer function (Pennacchio, et al. 2006; Shen, et al. 
2012). Experimental approaches often hinge on protein interactions with 
chromatin or accessibility of chromatin to infer the presence of regulatory 
elements. Chromatin immunoprecipitation followed by sequencing (ChIP-seq) of 
acetylated histones, for example, can identify putative enhancers and promoters 
on a genome-wide scale. Similarly, ChIP-seq for a specific transcription factor 
can identify CREs to which a given transcription factor binds. The physiological 
context in which experimental methods are used to identify putative CREs is 
important since chromatin accessibility can change between cell types and ChIP-
seq typically identifies proteins bound to regions of open chromatin.  
 Both experimental and computational approaches to identifying CREs 
have an important caveat. The elements they identify have characteristics 
 
 49 
associated with functional elements, but the level and cellular context of their 
activity remain unknown. The classic approach to testing the function of a 
putative regulatory sequence is a reporter assay in which a candidate sequence 
is cloned into a plasmid upstream of a promoter and reporter gene, and then 
transfected into cells to test the ability of the candidate sequence to drive 
expression of the reporter gene. This approach uses a one-by-one testing 
method that is low-throughput and only able to test sequences in cells amenable 
to transfection of the reporter construct. Leveraging next-generation sequencing, 
massively parallel reporter assays are capable of testing thousands of candidate 
regulatory sequences in a single assay (Inoue and Ahituv 2015; White 2015). In 
principle these assays use a similar design to conventional reporter assays, but 
use transcribed CRE-specific unique molecular identifiers as a way of measuring 
reporter transcription. 
 Given that evolution within regulatory sequences can confer adaptive 
phenotypes, we were interested in characterizing putative enhancers that may 
have had adaptive roles in shaping unique neural phenotypes in humans. Here 
we used a multifaceted approach to identify putative CREs that likely have 
functional consequence for human phenotypes. First, we chose to assay highly 
conserved non-coding sequences that have increased substitution rate in 
humans, including those defined as human accelerated regions (HARs) 
(Lindblad-Toh, et al. 2011; Pollard, et al. 2006; Prabhakar, et al. 2006). Because 
these sequences have higher than expected rates of substitution in humans they 
may contribute to important differences in human development. Secondly, we 
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also chose to assay sequences that have chromatin marks (H3K27ac, and 
H3K4me2) associated with active enhancers that were identified in developing or 
adult human brain (Reilly, et al. 2015; Vermunt, et al. 2014; Vermunt, et al. 
2016). By choosing to assay CREs with putative roles in development or activity 
in neural cells, we thereby focused our analysis on CREs that may contribute to 
human-specific gene regulation. To learn about how human-specific changes in 
CREs influence transcriptional activity, we also tested orthologous chimpanzee 
sequences along with these candidate human CREs. This combination of CREs 
that experienced recent selection in humans and CREs that are functional brain 
enhancers presents a novel way of studying the evolution of non-coding 
elements that contribute to human neural phenotypes. 
 We functionally tested candidate CREs with a lentiviral-based MPRA in 
induced pluripotent stem cell (iPSC)-derived neural progenitor cells and neurons 
to assay CREs in a physiologically relevant context. Using a lentiviral vector, 
CRE-reporter constructs integrate into the genome, which allows for transcription 
from chromatin instead of an episomal vector, and allows for transduction of 
neural cell types that can be more sensitive to conventional transfection 
techniques (Inoue, et al. 2017). In this assay we identified 179 CREs that have 
differential activity between human and chimpanzee orthologs and characterize 
sequences changes that give rise to new transcription factor binding motifs within 
CREs. We also find many of the CREs in our assay in loci that contain GWAS 
SNPs associated with neuropsychiatric diseases, which highlights the important 
functional consequences that can arise from variation in these non-coding 
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regions. Finally, by looking at the genomic distribution of CREs with signs of 
selection in our assay, we identify and focus on the Wnt signaling pathway as a 
frequent target of positive selection in humans, which could have consequences 
for human neural phenotypes in both health and disease. 
3.3 Results 
3.3.1 MPRA in NPCs and neurons identifies differentially expressed CREs 
 To identify CREs that might have differences in function between humans 
and chimpanzees, we used a multi-pronged approach and tested genomic 
regions that have experienced positive selection or have active chromatin marks 
from brain tissue in humans (Figure 3.1A) (Lindblad-Toh, et al. 2011; Pollard, et 
al. 2006; Prabhakar, et al. 2006; Reilly, et al. 2015; Vermunt, et al. 2014; 
Vermunt, et al. 2016). Human accelerated regions (HARs) are sequences of 
conserved non-coding DNA that have accelerated rates of substitutions in 
humans (Lindblad-Toh, et al. 2011; Pollard, et al. 2006; Prabhakar, et al. 2006). 
Regions with histone marks associated with enhancers were identified in adult or 
developing human brain or have histone marks for enhancers in cortical areas of 
brain tissue in human but not chimpanzee (Reilly, et al. 2015; Vermunt, et al. 
2014; Vermunt, et al. 2016). 
 We designed our MPRA library to test a total of 2274 pairs of human-
chimpanzee orthologous CREs. This set includes 1579 CREs with signs of 
accelerated rates of substitution in human sequences, "accelerated CREs," and 
695 CREs that are associated with ChIP-seq-defined enhancers in human brain 
samples, "brain CREs."  All of the accelerated CREs from our literature sources 
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were included, but the ChIP-seq data sets include many more putative CREs 
than we can test in our assay. To select brain CREs for our assay we randomly 
chose sequences from all combined ChIP-seq sources to fill in remaining the 
remaining elements in our library. CRE sequences were synthesized as 230bp 
oligomers (Agilent Technologies) that were cloned into a lentiviral transfer 
plasmid (see Methods). The final lentiviral reporter constructs have CRE 
sequences upstream of a minimal promoter and EGFP reporter gene, each with 
a unique barcode in the 3'UTR. The lentiviral MPRA library was packaged into 
viral particles and used to transduce iPSC-derived NPCs and neurons (Figure 
3.1B, C). We tested 3 biological replicates for each human and chimpanzee and 
for both iPSC-derived NPCs and neurons, with a total of 12 replicates. Total RNA 
and DNA were collected 48 hours after infection and barcode amplicons were 
sequenced to quantify CRE expression. 
 Our initial library consisted of 2274 CREs in the designed array. While not 
all of these were active in our assay, we refer to these as the "background" set in 
subsequent analyses. We found 1157 CREs that were represented by both 
species orthologs in these cells, and further filtered these to 268 that were active 
in at least 2 of 3 replicates of either species cell type (Figure 3.2A). We used 
limma (Ritchie, et al. 2015) to test for differential expression between orthologous 
CREs across all replicates and found 179 CREs that have significantly different 
(p-value < 0.05) levels of activity between orthologs (Figure 3.2B). 
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3.3.2 Many MPRA CREs have signs of positive selection 
 To investigate adaptive non-coding changes, we tested CREs with signs 
of accelerated evolution in humans. Since the CREs in our assay came from 
different sources, and a subset of those hadn't been tested for signs of selection 
(from chromatin assays, not bioinformatic scans), we performed our own test for 
positive selection in the human CREs. We used the method described by 
(Haygood, et al. 2007) and executable in HyPhy (Pond, et al. 2005). This test 
calculates nucleotide substitution rates in a given non-coding sequence, using a 
human-chimpanzee-macaque sequence alignment in this case, and compares 
that to a neutral substitution rate approximated from intronic (excluding first 
introns) and intergenic regions within 100kb of CRE sequences. It is analogous 
to a dN/dS test, where a higher substitution rate in the CRE sequence compared 
to the neutral sequence is used to infer positive selection. Not all sequences 
aligned between the human, chimpanzee, and macaque genomes, so we tested 
1891 CREs for which sequence alignments were available. We found 722 with 
signs of positive selection using a likelihood ratio test with a significance p-value 
< 0.05. We classified selection in CREs based on individual p-values instead of 
adjusting for multiple testing to make the selection criteria as inclusive as 
possible. We defined this set of "selection CREs" as a way to look at the activity 
and characteristics of enhancers that experienced recent evolution in humans. 
3.3.3 Gene ontology enrichments are similar across CRE sets 
 We next wanted to see if CREs in different subsets represent similar 
biological processes, so we compared enriched gene ontology (GO) terms 
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between selection, background, tested, active, and DE CREs. While the tested 
and active CREs represent portions of the background set after filtering for 
activity in our assay, selection and DE CREs belong to fairly distinct groups. The 
selection CREs have signs of accelerated substitution in humans whereas the 
DE CREs have significant differences in activity between human and 
chimpanzee orthologs. Between 722 selection and 179 DE CREs, there are only 
34 CREs that have signs of selection and are differentially expressed between 
orthologs, so the selection and DE CREs are mostly distinct sets. We assigned 
CREs to their nearest 5' and 3' genes with GREAT (McLean, et al. 2010) and 
performed gene ontology enrichment analysis with gProfiler (Raudvere, et al. 
2019). We grouped enriched terms (q-value < 0.05) into broad category types to 
see if different types of processes were similarly represented in CRE sets, and 
tested similarity of enriched terms between CRE sets using GO SemSim (Yu, et 
al. 2010) which compares semantic similarity between sets of GO terms and is a 
way to quantify similarity between sets of enrichments.  
 While the sets of tested and selection CREs have similar representation of 
different types of biological processes and a high measure of semantic similarity 
to background, the active and DE CREs look to have less diversity in their 
representation of biological processes and lower semantic similarity scores 
(Figure 3.2C, D). In order to investigate if this was because these sets have 
fewer CREs or if the CREs in these sets represent a narrower range of 
processes, we drew 10 random samples of 179 CREs (the same as the number 
of DE CREs) from the background set and compared the enriched GO terms. 
 
 55 
The randomly sampled sets often (6/10) show more diversity of enriched terms 
and more similar semantic similarity scores than DE CREs (Supplementary 
Figure 3.1). There are some (4/10) randomly sampled sets, however, that have 
similar or lower diversity than DE CREs, which suggests the decreased diversity 
of enriched terms from active and DE CREs is due to the smaller number of CRE 
in these sets. 
3.3.4 Selection CREs are more distal to genes and other enhancers 
 Putative CREs occur widely throughout the genome but their genomic 
locations are not random. The distances between conserved non-coding 
sequences (CNSs), and between CNSs and the nearest gene, are conserved 
between avian and mammalian genomes (Babarinde and Saitou 2016; Sun, et 
al. 2006) and there is evidence that pairs of adjacent CNSs act together in a 
distance-sensitive way (Li, et al. 2018). Genomic locations may also inform about 
function of regulatory elements. Zabidi (Zabidi, et al. 2015) report that 
housekeeping enhancers overlap or are proximal with TSSs whereas 
developmental enhancers are mostly intergenic or intronic.  
 Given that there are differences in the genomic distribution of CREs, we 
were interested to learn if there are particular genomic characteristics that are 
more associated with CREs under selection or CREs that are differentially 
expressed between orthologs. We first wanted to look at where CREs are located 
in relation to nearby genes and other putative regulatory elements. To look at 
genomic locations, we downloaded reference datasets for transcription start sites 
from Ensembl release 98 (Zerbino, et al. 2018), and used histone acetylation and 
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methylation ChIP-seq data sets from our brain CRE sources (Reilly, et al. 2015; 
Vermunt, et al. 2014) to identify other neural-active regulatory elements. For 
each CRE, we counted the number of annotated TSSs and putative enhancers 
within 1Mb. Selection CREs are generally near fewer TSSs and putative 
enhancers than the background CRE set, while DE CREs are in regions with 
greater numbers of TSSs but not necessarily more enhancers (Figure 3.3A, B). 
While the average differences are not great, they are statistically significant, 
which can indicate an overall trend in genomic location.  
3.3.5 Selection CREs are smaller but belong to larger regulatory domains 
 We were next interested to see how the size of regulatory elements differs 
between CRE sets. Based on CRE origins and tissue specificity, there is some 
evidence that different types of CREs differ in size. For example, Moon et al. 
(Moon, et al. 2019) show that there are not significant differences in length 
between enhancers with signs of positive selection and those without selection, 
but there are differences in enhancer length specifically in brain and testis 
enhancers. We looked at the size distribution of CREs in our assay and found 
that CREs with signs of selection are significantly smaller than background, while 
DE CREs are significantly larger than background (Figure 3.3C). However, the 
size difference between CREs is influenced by their original identification 
methods. Most selection CREs were identified computationally by searching for 
highly conserved sequences in animals. HARs have an average size of 257bp 
and more evolutionarily ancient mammalian conserved non-coding sequences 
are even shorter (Capra, et al. 2013). In our assay, selection CREs, most of 
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which are HARs, are contrasted with CREs identified from ChIP-seq datasets 
that have an average size of 1932bp, so part of the difference in size that we see 
is due to the methods that were originally used to define these CREs. 
 To further compare selection and DE CREs, we looked for overlap 
between our CREs and functionally active regulatory elements in the human 
brain (Reilly, et al. 2015; Vermunt, et al. 2014). We compared the size of the 
brain enhancers that overlap our selection or DE CREs and found that selection 
CREs overlap with larger regions compared DE CREs (Figure 3.3D). The larger 
regions to which selection CREs belong may then be related to the way that 
enhancers evolved around regions with highly conserved sequences. Sequences 
adjacent to highly conserved regions can evolve functions to help modulate 
ancestral expression patterns in new spatiotemporal ways. Over time, addition of 
new functional elements can increase the size of an enhancer (Emera, et al. 
2016).  
 Larger CREs could contain more functional elements that contribute more 
transcriptional output and thus higher activity. Indeed, DE CREs are larger and 
have higher activity than background and selection CREs (Figure 3.3G). We 
wanted to determine if increased activity is due to larger CRE size, so we tested 
for a correlation between size and activity. Overall, we did not find a strong 
relationship and only see a weak correlation in chimpanzee CREs (Spearman's 
rho = 0.216, p-value = 0.0002). So, while DE CREs are larger, it doesn't seem 
that their higher activity is due to their larger size. 
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3.3.6 Selection CREs have significantly lower GC content 
 One of the sequence characteristics that can differentiate enhancers is 
GC content. Chen et al. (Chen, et al. 2018) report a positive correlation between 
enhancer GC content and activity, and Colbran et al. (Colbran, et al. 2017) report 
that GC dinucleotides are associated with broad enhancer activity. Overall the 
GC content in the human genome is about 42%, but that rate can be lower in 
CNSs. In sequences that are conserved among mammals the GC content is 
lower than background, about 37%, whereas those that are only conserved 
among primates have GC content that is similar to the genomic background 
(Babarinde and Saitou 2013). This difference is likely due to the presence of 
lineage-specific TF motifs that have lower GC content compared to ubiquitous TF 
motifs (Hettiarachchi and Saitou 2016). Changes in GC content can also occur in 
the genome by the recombination driven process of GC-biased gene conversion 
(gBGC) (Galtier and Duret 2007). Although this is a neutral process, changes in 
GC content in conserved non-coding sequences could contribute to an increased 
substitution rate that mimics positive selection (Kostka, et al. 2012). 
 We looked at the GC content of CREs in our assay and found that 
selection CREs have lower GC content than background in both human and 
chimpanzee sequences, while GC content in DE CREs is not significantly 
different from background (Figure 3.3E,F). The lower GC content that we 
observed in selection CREs suggests that gBGC is not driving selection signals 
in these CREs. The proportions of G and C nucleotides in selection CREs is in 
agreement with the reported decreased GC content in mammalian conserved 
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CNSs and supports putative functions for selection CREs as lineage-specific 
developmental enhancers. This contrasts with DE CREs that may have arisen 
more recently and perhaps function in a more general way. We also looked for 
correlations between GC content and CRE activity within each CRE set, but 
overall we do not see a strong relationship. There are weak positive correlations 
in chimpanzee CREs (Spearman's rho = 0.114, p-value = 0.031) and human DE 
CREs (Spearman's rho = 0.179, p-value = 0.038), but these values are low and 
do not indicate that GC content is driving differences in activity (Supplementary 
Figure 3.2). 
 We were next interested to see if CpG content differed between CRE sets. 
CpG deamination was previously identified as a significant mechanism of 
sequence evolution in primate enhancers (Klein, et al. 2018). We scanned all of 
our CREs for CpG motifs and found lower CpG content in chimpanzee selection 
CREs compared to background (Supplementary Figure 3.3). It does not seem 
that this difference is because of lower GC content however, because human 
CREs also have low GC content but not significantly lower CpG motifs. 
Comparing CpGs between human and chimpanzee shows a slightly, but not 
significantly higher number of CpGs in human than chimpanzee. These data 
suggest that CpG deamination is not a strong driver of sequence evolution in the 
CREs that we assayed. 
3.3.7 Selection CREs have fewer TF motifs but more TF gains in humans 
 Enhancer activity is largely defined by the binding of transcription factors 
to specific motifs, which results in the recruitment of transcriptional machinery to 
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promoters to activate transcription of a target gene. Since TF motifs are the basic 
functional units within enhancers, we wanted to see if there were differences in 
motif abundance between CREs in our assay. To explore this, we scanned 
human and chimpanzee CRE sequences for JASPAR motifs (Khan, et al. 2018) 
using FIMO (Grant, et al. 2011) with a p-value cutoff of 10-4. We first looked at 
the overall density of TF motifs in selection, DE, and background CREs and 
compared that to random non-coding genomic regions (see Methods) to see if TF 
motif density was higher in our CREs than the genomic average. To normalize 
for CRE size, we calculated TF motif occurrences per 100bp. Across all 
sequences tested, the average motif density is ~15 motifs/ 100bp, but in both 
human and chimpanzee CREs the average is slightly higher than genomic 
background, with the exception of human selection CREs that are slightly lower 
(14.9 motifs/ 100bp) (Supplementary Figure 3.4A). Although the distributions 
overlap across all sequences tested, the average motif density in both human 
and chimpanzee selection CREs is significantly (p < 0.006) lower in all 
comparisons (Supplementary Figure 3.4B). 
 In general the activity of selection CREs is lower in our assay compared to 
DE or background CREs (Figure 3.3G), so we checked if there was a relationship 
between TF motif density and CRE activity by comparing the normalized counts 
across all replicates for each CRE to the total number of TF motifs per CRE. For 
all human and chimpanzee background CREs there is a weak to moderate 
positive correlation between motif number and activity (Spearman's rho = 0.164, 
p = 0.030 human; rho = 0.331, p = 1.795e-5 chimpanzee) (Figure 3.4). There is 
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also a similar relationship in chimpanzee selection CREs (rho = 0.286, p = 
0.018), but not in other CRE sets. Overall, the abundance of TF motifs in a 
sequence is not a strong predictor, but in some cases may inform about CRE 
activity. The presence of a TF motif in a DNA sequence doesn't necessarily 
indicate that a given TF binds at that location. Likewise, the absence of a TF 
motif doesn't mean that a TF does not bind a particular sequence. TF binding can 
occur in a cooperative way such that nearby transcription factors bound to an 
enhancer can recruit cofactors to sequences that don't match predicted motifs 
(Grossman, et al. 2017; Rubinstein and de Souza 2013). TF binding to 
enhancers is context dependent, but nonetheless, scanning for motifs can 
provide insight into which sites in an enhancer might be active and how 
sequences are evolving. 
 Since changes in TF motif abundance can contribute to differential activity, 
we next looked at global differences in TF motif occurrences between human and 
chimpanzee CREs. For each motif, we calculated the total number of 
occurrences in human and chimpanzee sequences. To find motifs that occur at 
significantly different frequencies between species, we focused on those for 
which the fold-change between human and chimpanzee was at least two 
standard deviations from the mean, and performed this calculation for all 
background, selection, and DE CREs. 
 Across all CREs there are 17 motifs that are significantly more abundant 
in humans and 4 that are more abundant in chimpanzee (Supplementary Table 
3.1). In human CREs, MSX3, MSX2, CUX2, and CEBPG occur at 15-35% 
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increased frequency compared to chimpanzee. In chimpanzee CREs ZNF740, 
GMEB1, and PDX1 motifs are 14-19% more abundant than in human while LBX1 
motifs are 113% more abundant.  
 We wanted to know if there were particular motifs that experienced 
significant changes in frequency in selection and DE CREs, but also wanted to 
separate out background effects due to global changes in TF frequency between 
species. To do this we calculated the difference in the human-chimpanzee fold-
change between selection or DE CREs and background. We then focused on 
motifs that were changing significantly more or less (> 2 standard deviations from 
the mean fold-change difference) in selection and DE CREs. This shows us the 
motifs that are changing at a much faster rate in selection and DE CREs 
compared to background changes. In both human and chimpanzee DE CREs, 
the numbers of motifs with increased and decreased rate of change compared to 
background are similar (Supplementary Table 3.1). This could suggest that these 
regions are experiencing a higher rate of TF turnover and could be regulatory 
sites that are under less constraint. In humans DE CREs there are three motifs, 
CUX2, CBP, and ZBTB33 that changing ~50% higher human-gain rate than 
background. In chimpanzee DE CREs, CREM and GMEB2 experienced a much 
faster loss than background. In the selection CREs, there are 12 motifs that are 
changing significantly more between species than the background including 
GMEB1/2, ZBTB33, and CEBPD/G/E/B, and CREB3, and only 1 motif (E2F3) 
that is significantly more depleted in human selection CREs than background 
(Supplementary Table 3.1). This suggests that positive selection in human CREs 
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favors the appearance of specific motifs more than the depletion of motifs, and 
that these changes are not due to general trends towards increased or 
decreased frequency of motifs in the human genome.  
3.3.8 Many differentially expressed CREs are associated with 
neuropsychiatric SNPs 
 CREs that contribute to differential gene regulation between humans and 
chimpanzees may contribute to human specific neural phenotypes. At the same 
time, regulatory changes that bring about adaptive physiological changes could 
contribute to increased human susceptibility to neuropsychiatric diseases (Won, 
et al. 2019). GWAS SNPs associated with neuropsychiatric diseases fall mostly 
in non-coding regions of the genome (Gallagher and Chen-Plotkin 2018; Schaub, 
et al. 2012), which supports the hypothesis that regulatory variation is an 
important driver of disease phenotypes. As a way to explore how regulatory 
changes could be impacting physiological processes important for human 
specific neural phenotypes, we looked for loci that contain CREs and 
neuropsychiatric SNPs. We first collected GWAS SNPs from the NHGRI-EBI 
catalog (Buniello, et al. 2019) associated with Alzheimer's disease, autism, 
attention deficit hyperactivity disorder, bipolar disorder, major depressive 
disorder, or schizophrenia. We then associated SNPs and CREs with their 
nearest genes using GREAT. With this approach we found 85 genes associated 
with 69 CREs, 46 of which are DE CREs, and 85 SNPs (Supplementary Table 
3.2). Genes associated with CREs and SNPs represent a large range of 
biological processes that have important roles in development and neural 
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function including axon growth and guidance, synapse formation, cell adhesion, 
DNA replication, calcium signaling, glutamate signaling, Wnt signaling, and 
regulation of transcription.  
 We define GWAS loci as the regions around genes that share at least one 
SNP and one CRE. Spatially, overall, we do not see clear patterns in the 
locations of SNPs and CREs relative to genes. The median size of the loci we 
identified is 327kb. About 70% of CREs and ~72% of SNPs occur in introns, and 
~23% of CREs and ~22% of SNPs are intergenic. The average distance between 
SNPs and the closest TSS is approximately 300kb and, on average, CREs are 
about 335kb away from TSSs. Given that non-coding SNPs contribute to 
diseases by impacting regulation of gene expression, this highlights the fact that 
variation in non-coding regions, even those that are quite far from target genes, 
can have impacts on phenotypes. While CREs putatively function through 
regulation of target gene transcription, SNPs in non-coding regions could 
influence gene expression through modification of distal enhancer function or 
could be part of unannotated transcripts or RNA genes, that act in trans to 
modulate expression of target genes. Although we do not have data that describe 
chromatin interaction in our specific cell lines, Hi-C datasets that identify 
genome-wide chromatin interactions (van Berkum, et al. 2010) in comparable cell 
types or from human brain regions can shed light on how distal non-coding 
regions can interact with surrounding genes (Figure 3.5). 
 To look more closely at how regulatory changes could be impacting gene 
expression in the human brain, we looked for loci that have GWAS SNPs and 
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CREs that are differentially expressed between species. We also used Hi-C data 
from human prefrontal cortex (Schmitt, et al. 2016) to visualize how SNPs and 
CREs might be interacting with surrounding genomic regions. These data inform 
about long-range interactions that form topologically associated domains (TADs) 
through DNA looping and bring distal parts of chromosomes into close physical 
proximity (Dixon, et al. 2012). Although the CRE and SNP locations relative to 
putative targets vary between all CRE-SNP associations, we focus on several 
loci to highlight these relationships (Figure 3.5).  
 In the region around FAT1, an atypical cadherin, CRE.2063 and 
rs75718659, an Alzheimer's disease associated variant (Figure 3.5E), are 
located 1.2kb away from each other and ~98 kb upstream of FAT1 (Figure 3.5A). 
Chromatin interactions in this region suggest that CRE.2063 and rs75718659 
could physically interact with the FAT1 promoter and with several upstream long 
non-coding RNA genes. In several cases we see CREs located in the introns of 
genes. In AUTS2, which is part of a chromatin remodeling complex and is linked 
to autism spectrum disorder, CRE.2165 and rs10237317, a variant associated 
with bipolar disorder (Figure 3.5E), are located in the 5th intron (Figure 3.5C). 
The 3' end of AUTS2 aligns with the boundary of a two TADs, which suggests 
that contacts between AUTS2 and downstream sequences are limited. In another 
region, CRE.1971 is in the second intron of LARGE1, a glycotransferase that is 
required for α-dystroglycan binding to laminin and neurexins (Inamori, et al. 
2016) (Figure 3.5D). Downstream of LARGE1, but in a separate TAD, is SYN3, a 
synapsin gene associated with synaptic vesicles that has rs114368656, a variant 
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linked to Alzheimer's disease and bipolar disorder (Figure 3.5E) in the sixth 
intron. In another locus, CRE.2112 is located in the third intron of GRM4, a 
metabotropic glutamate receptor. These features are located inside their putative 
targets and have some evidence of interactions with their respective promoters 
and neighboring regions. Chromatin interaction data suggest that frequency of 
interactions increase with proximity to TSS and that TSS interactions with 
upstream elements are more common (Sanyal, et al. 2012), so their putative 
functions of proximal and upstream elements are more easily defined. In loci 
where variants are located in intergenic regions, long non-coding RNAs, or 
unannotated transcripts, target genes and their role in neural phenotypes are 
less clear. Variant rs61580878, associated with bipolar disorder (Figure 3.5E), is 
located in the third intron of LINC01643, a long non-coding RNA (Figure 3.5D), 
and variant rs16869652, associated with schizophrenia (Figure 3.5E), located in 
an intergenic region ~80kb upstream of the motilin gene MLN. This gene shows 
expression in the brain, but its annotated function as a regulator of 
gastrointestinal contractions makes its consequence for neural phenotypes less 
clear. 
3.3.9 Many genes in the Wnt pathway have signs of positive selection in 
surrounding non-coding regions 
 Human-specific differences in the regulation of gene expression can 
manifest in several ways. Our analysis of DE CREs associated with GWAS SNPs 
shows that human CREs can gain or lose activity compared with orthologous 
chimpanzee sequences. These differences in activity are only in one context, 
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however, and the influence of these CREs on gene expression could change in a 
spatiotemporal way as chromatin conformation and as the population of trans-
acting regulatory elements changes. However, changes in the activity of 
regulatory elements may not be overt, as are expression differences in many DE 
CREs. Evolution within regulatory sequences can act in subtle ways to fine tune 
CRE activity (Farley, et al. 2015). In many cases it many not be beneficial to 
make significant changes in a regulatory network. Highly conserved 
developmental pathways, for example, may be sensitive to regulatory changes 
that could have broad effects on development. Given this, when we looked at 
GWAS SNPs near CREs in our assay, we were surprised to see DE and 
selection CREs around genes in the Wnt pathway, which controls body 
patterning, cell differentiation and proliferation, and has important roles in 
embryonic and adult neural development and function (Ciani and Salinas 2005; 
Logan and Nusse 2004; Patapoutian and Reichardt 2000). Considering the Wnt 
pathway has essential roles in early development and neural function we focused 
on Wnt to explore how selection could be acting to influence a core 
developmental pathway. 
 To look at how selection might be acting around genes involved in Wnt 
signaling we looked for CREs with signs of positive selection within 500kb of 
genes in this pathway. We collected genes that are part of annotated gene sets 
in the mSigDB (Subramanian, et al. 2005) under the headings "wnt signaling," 
"GO canonical Wnt signaling pathway," and "KEGG Wnt signaling pathway." We 
then looked to see if any of the 722 CREs with signals of positive selection in our 
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assay were within 500kb of canonical Wnt pathway genes or if DE CREs were 
associated with these genes. Some genes that were part of annotated Wnt 
pathway gene sets do not have specific functions that are well defined, so we 
focused our analysis on genes that have well defined functions in this pathway. 
In total, we found 59 CREs within 500kb of 47 genes in the Wnt pathway 
(Supplementary Table 3.3). Of these, 44 are selection CREs and 16 are DE 
CREs, while only one is both DE and under selection.  
 CREs with signs of positive selection are associated with many genes in 
the canonical Wnt signaling pathway (Komiya and Habas 2008; MacDonald, et 
al. 2009), and also with many of the genes that modulate Wnt signaling (see 
Methods for references) (Figure 3.6). Some of these genes are associated with 
multiple CREs that have different selection and expression profiles. These data 
were condensed in our representation but are elaborated in Table 3.1. Some of 
the major genes in this pathway have CREs with signs of selection including 
WNT2, WNT5A, and WNT8B, and Frizzled receptors FZD5, FZD6, and FZD7. 
Additionally, the human ortholog of a CRE near FZD1 is differentially expressed. 
Frizzled proteins are the primary receptors for Wnt ligands, and differential 
expression and function of a human accelerated enhancer was previously 
described near FZD8 (Boyd, et al. 2015). The primary mediator of Wnt signaling 
is β-catenin that helps regulate transcription of Wnt target genes. Levels of β-
catenin in the cell are controlled in part by the kinase GSK3β that phosphorylates 
and leads to degradation of β-catenin. Thus, GSK3β is one of the core proteins in 
this pathway and has an enhancer under positive selection ~170kb away. 
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 While there are only a relatively small number of core proteins involved in 
Wnt signal transduction, there are many proteins that help modulate signaling. In 
general this happens through affecting Wnt binding to receptors, direct or indirect 
inhibition of GSK3β, control of β-catenin translocation, control of β-catenin 
association with the transcription activation complex, or inhibition of the 
transcription activation complex itself. CREs under selection and DE CREs are 
associated with genes involved in all of these processes (Figure 3.6). However, 
DE CREs are not enriched in any one part of the pathway and changes in CRE 
activity in humans do not tend to increase or decrease Wnt signal transduction. 
Interestingly, the only part of the core Wnt signaling pathway that has evidence of 
differential gene regulation is the FZD1 receptor that helps to initiate Wnt 
signaling. Although we have only tested ~20 of these CREs, and there are likely 
many regulatory regions that differ in activity around these genes, it does appear 
that DE CREs, with the exception of a DE CRE near FZD1, generally are 
associated with genes that act peripherally to the core pathway. Because Wnt 
signaling is critical in animal development, and modifications of the system could 
be deleterious, it is not surprising that we do not see much differential gene 
regulation in core components of the pathway. Yet, at the same time, this 
underscores the significance of adaptive changes occurring at the critical first 
step of Wnt signaling. Selection, however, does appear to be acting in regulatory 
regions throughout the Wnt pathway. CREs with signs of positive selection could 
be helping to control Wnt signaling in specific contexts by fine-tuning expression 
patterns. In comparison to selection in regulatory regions, protein coding regions 
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of Wnt signaling genes are highly conserved. To test for signs of selection in 
coding regions we calculated rates of nonsynonymous (dN) to synonymous (dS) 
substitutions in human sequences compared to chimpanzee for 31 of 47 genes 
for which Ensembl release 98 (Zerbino, et al. 2018) data were available, and only 
found a dN/dS > 1 in MYC, which is a downstream effector of Wnt signaling. 
 Because we tested CREs in both NPCs and neurons, we were curious if 
we could see differences in the activity of CREs between cell types in the Wnt 
pathway. We tested human and chimpanzee CREs separately for differential 
activity in NPCs and neurons and found several that overlap with Wnt pathway 
genes. Most of these have higher activity in NPC with the exception of CREs 
associated with genes that compose the proteasome and STK4 that have higher 
activity in neurons (Figure 3.6). This could suggest that there is a higher level of 
regulation of Wnt signaling in less mature neural cells. The CREs that are more 
active in neurons are also less Wnt-specific. STK4 is a kinase that is part of the 
MAP kinase signaling pathway, and the proteasome is a ubiquitous protein 
complex essential cellular processes.  
 To look at how selection is working in Wnt pathway CREs, we aligned 
sequences between human and chimpanzee and looked for mutations that 
overlap with TF motifs from our earlier scan for JASPAR motifs. In many cases, 
mutations result in the appearance of new motifs in human CREs, but most often 
mutations modify existing motifs; we found 698 new motifs in 59 Wnt-pathway 
CREs, and 1572 existing motifs affected by mutations (Supplementary Table 
3.4). Among the motifs with new occurrences in human CREs, ZNF384 has the 
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most new motifs, followed by Zfx, SP3, E2F4, TP73, IRF1, ZNF263, and 
TFAP2C(var.2), all with six or more new occurrences. The existing motifs that 
most frequently overlap mutations are ZNF384, ZNF263, EWSR1-FLI1, IRF1, 
SP2, and SP1, each with 24 or more instances affected by mutations. 
Interestingly, most of the existing and new motif occurrences are also some of 
the most frequently occurring motifs among all the CREs in our assay. These 
data suggest that there isn't one subset of transcription factors that is driving 
evolution in regulatory elements around the Wnt pathway. Rather, changes in 
these CREs seem to be happening through modulation of existing binding sites 
with the appearance of additional sites that are already common in the genome.  
3.4 Discussion 
 Humans have experienced rapid evolution of neural phenotypes, but 
uncovering the adaptive genomic changes that control the developmental and 
functional processes responsible for these phenotypes has been one of the 
major challenges in evolutionary biology. Comparative genomics offers the 
opportunity to study evolution in the genome by comparing sequences between 
evolutionarily related species. Human-chimpanzee comparisons show a high 
similarity in coding sequences, suggesting that changes in gene regulation are 
responsible for phenotypic differences between species (King and Wilson 1975). 
While the ability to identify putative regulatory elements in the genome has 
accelerated due to advances in high-throughput sequencing, understanding the 
physiological roles of these sequences remains a challenge. 
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 In this study we combine computational and experimental genomic 
techniques to characterize the evolution and function of human neural enhancers 
in iPSC-derived NPCs and neurons that provide a physiologically relevant 
context for testing enhancers. By choosing highly conserved non-coding 
sequences that have accelerated evolution in humans (Lindblad-Toh, et al. 2011; 
Pollard, et al. 2006; Prabhakar, et al. 2006) along with experimentally defined 
enhancers active in the developing or adult human brain (Reilly, et al. 2015; 
Vermunt, et al. 2014; Vermunt, et al. 2016), we focused this assay on sequences 
that are enriched for neural and developmental processes which may be 
adaptive. Compared to other studies that, for example, focused only on human 
accelerated regions or dissect functional elements within smaller subsets of 
enhancers, we designed our assay with a global approach to include a broad set 
of enhancers that have putative functions in development or adult neural gene 
expression. In this way, we can explore how different types of enhancers have 
evolved to control neural phenotypes. 
 In our functional characterization, we identified 179 CREs that have 
significantly different activity between human and chimpanzee orthologs, and 
also found a set of 722 CREs under positive selection. CREs in these two sets 
are largely non-overlapping; only 34 are differentially expressed and have signs 
of positive selection. Furthermore, these CREs differ in genomic characteristics. 
Selection CREs are more distal to genes and other enhancers, are shorter 
sequences but belong to larger regulatory domains, and have lower GC content. 
When we looked at how TF motifs differ between humans and chimpanzees, we 
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saw that selection CREs generally show more TF gains than losses whereas 
motif gains and losses in human DE CREs are more balanced.  
 Our analysis of the genomic and TF motif characteristics of selection and 
DE CREs suggest functional differences between these CRE types, which agree 
with the patterns of expression that we observe in our assay. Selection CREs, 
which contain highly evolutionarily conserved sequences, have lower GC content 
than genomic background, which is associated with conserved non-coding 
sequences common among all mammals and is related to the composition of TF 
motifs within these sequences (Babarinde and Saitou 2013; Hettiarachchi and 
Saitou 2016). The preservation of ancestral sequences in selection CREs agrees 
with the observation that human accelerated enhancers have roles in regulating 
gene expression during development (Capra, et al. 2013). Furthermore, the 
relatively short sequences that compose selection CREs belong to larger 
enhancer regions. This observation is in line with the model proposed by Emera 
et al. (2016) who show that highly conserved non-coding sequences shared 
among mammals are parts of larger composite enhancers that contain ancestral 
enhancer cores and adjacent linage-specific regulatory sequences. Together with 
the observation that selection CREs experienced more TF gains than losses in 
human sequences, this suggests that adaptive changes in selection CREs 
preserve ancestral functions that are critical for their roles in development. 
Human specific changes in these sequences could provide ways to fine-tune 
activity without producing large changes in the activity of human sequences, 
which corresponds to our observation that there are few significant differences in 
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activity between human and chimpanzee selection CREs. These characteristics 
contrast with DE CREs that do not have highly conserved sequences, have GC 
content similar to background, and a higher rate of TF motif gains and losses. 
These data suggest that evolution of sequences in DE CREs is less constrained 
and that DE CREs are likely more recently evolved enhancers that could serve 
as a way to further define the level, location, or temporal dynamics of gene 
expression. 
 To look at how human CREs could be impacting neural phenotypes we 
looked for genetic loci that contain CREs in our assay and GWAS SNPs 
associated with neuropsychiatric diseases. GWAS SNPs are often located in 
non-coding regions of the genome and have been shown to impact transcription 
factor motifs, linking these variants to putatively functional regulatory sites 
(Gallagher and Chen-Plotkin 2018; Huo, et al. 2019; Schaub, et al. 2012). Many 
of the CREs that we found in these loci are differentially expressed between 
human and chimpanzee sequences. While individual DE CREs do not fully 
explain the regulatory landscape in these loci, the overall patterns show that 
human gene regulatory elements evolved gains and losses of activity around 
neural genes. Understanding the functional consequences of regulatory elements 
requires linking CREs to putative target genes, which is a challenge since 
enhancers can act distally and often have more than one target gene (ENCODE 
Project Consortium 2012). However, using multiple -omics tools and layering 
together these datasets can help us understand the larger context of regulatory 
function. First, the SNPs that are contained in our loci of interest are statistically 
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associated with neuropsychiatric disease, which implies that these non-coding 
variants have regulatory function. Second, the CREs in these loci are active brain 
enhancers, which connect these sequences to the regulation of neural 
processes. Third, these SNPs and CREs are contained within bioinformatically-
assigned gene regulatory domains, and these genes are enriched for neural and 
developmental processes. Fourth, Hi-C data show that CREs, SNPs, and nearby 
genes fall within TADs, and there is evidence of physical interaction between 
regulatory regions containing SNPs and CREs and gene promoters. Together, 
these multiple lines of evidence underscore the functional roles of these loci in 
directing development and function of neural cells, and suggest that many of the 
physiological processes affected by disease variants were also affected by 
evolutionary changes in the human genome. This also points to potential 
mechanisms for increased susceptibility to diseases that are much more 
common in humans; many of the evolutionarily changes that confer humans with 
unique phenotypes also increase the risk for diseases that disproportionately 
affect humans (Crespi 2010). Many of the neuropsychiatric diseases that are 
unique to humans may be the unavoidable consequence of variation in complex 
human traits (Stearns and Medzhitov 2016). 
 As we explored CREs associated with neural development and function, 
we found an abundance of CREs around genes associated with canonical Wnt 
signaling. Throughout the pathway we found CREs with signs of positive 
selection and in general, DE CREs associated with genes that modulate Wnt 
signaling. One notable exception was a DE CRE with higher activity in the human 
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ortholog associated with FZD1, which has been shown to be important for 
neurogenesis in the hippocampus (Mardones, et al. 2016). Frizzled receptors are 
one of the primary receptors for Wnt ligands and mediate the initial events in the 
Wnt signaling cascade (MacDonald, et al. 2009; Nusse and Clevers 2017). Work 
by Boyd et al. (2015), showed that a human accelerated enhancer, HARE5, 
upstream of FZD8, accelerates the cell cycle in neural progenitors leading to an 
increased number of neurons and greater cortical expansion in transgenic mice 
than the orthologous chimpanzee enhancer. In our assay we also found CREs 
with signs of positive selection around three other frizzled paralogs, FZD5, 6, and 
7. Because Wnt interaction with frizzled receptors initiates signaling, changes in 
these upstream signaling elements have potentially larger impacts on the 
signaling cascade than changes in downstream signaling elements, and the 
differential enhancer activity of HARE5 highlights the significant impacts that 
changes in frizzled receptors have on morphology of the developing neocortex. 
In our assay we also found some differences in the trans environment in which 
Wnt pathway CREs are active. We found more CREs with higher activity in NPCs 
than neurons suggesting greater control of Wnt regulation in less mature neural 
cells. This differential regulation in neural progenitors corresponds with the role of 
Wnt signaling in controlling cellular proliferation. Together with the evidence for 
positive selection and differential CRE expression throughout the Wnt pathway, 
these data underscore the significance of the impacts that gene regulatory 
changes can have on driving differential neural phenotypes.  
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 MPRAs are powerful tools for functionally testing large numbers of 
putative regulatory elements in a single assay. Here we have applied it broadly to 
putative regulatory elements throughout the genome to examine the function of 
human neural enhancers. We have identified enhancers that have significant 
differences in activity between humans and chimpanzees that are strong 
candidates for follow-up validation with traditional reporter assays. Linking CREs 
to target genes with assays like chromatin conformation capture can further 
elucidate regulatory interactions and can be used to identify other enhancers that 
contribute to a gene's regulatory network. The activity defined here, however, is 
only in one physiological context, so a better understanding of when and where 
enhancers are active requires testing in other cell types or with in vivo assays.  
3.5 Methods 
3.5.1 Library Design 
 We sought to assay a diverse set of putative regulatory elements that 
either show signs of positive selection in humans, are active during neural 
development, have higher activity in the human cortex than other regions, or 
have higher levels of active chromatin marks in the human brain compared to 
other primates. We chose non-coding regions with accelerated rates of 
nucleotide substitution in humans that were previously described by Pollard et al. 
(2006), Lindblad-Toh et al. (2011), Prabhakar et al. (2006), and Haygood et al. 
(2007), the "accelerated CREs," and brain regions described by Reilly et al. 
(2015), and Vermunt et al. (2014; 2016) the "brain CREs." Coordinates were 
converted to hg38 space using liftOver (Hinrichs, et al. 2006) and sites in the 
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accelerated or brain sets were merged to combine overlapping sequences. Sites 
in the brain set were filtered by size to include only those between 200 bp and 
5000 bp in length. To enrich our set for more distal regulatory elements, we 
removed sites from the brain set that were within 1 kb of Ensembl release 98 
annotated transcription start sites (Zerbino, et al. 2018). Any coordinates that 
were part of the accelerated set were removed from the brain set. 
 We used 171bp sequences to construct our MPRA library. Regions 
smaller than this were appended with adjacent genomic regions, and 10 bp 
overlapping tiles were designed to cover larger regions. We first constructed tiles 
using hg38 coordinates and then mapped those to the chimpanzee (panTro5) 
genome using liftOver (Hinrichs, et al. 2006). Human coordinates that did not 
map to chimpanzee were removed. To build oligos of the same length, 
chimpanzee sequences were designed to end 171 bp away from the liftOver-
generated starting coordinate. We chose 1579 accelerated sites covered by 2857 
oligos, and randomly chose 695 brain sites covered by 5475 oligos. In total, our 
library represented 2274 orthologous pairs of CREs. Accelerated CREs were 
numbered CRE.1 through CRE.1579, and brain CREs were numbered 
CRE.1580 through CRE.2274.  
 Each 171 bp oligo sequence was represented in the library with six unique 
11 bp barcodes. Sequences or barcodes containing ClaI or SalI restriction sites 
were removed. Barcodes were filtered to remove homotrimers, and GC content 
was either 45 or 55%. One nonsense control was included in the library and was 
represented with 16 unique barcodes. The library was thus composed of 100,000 
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sequences. CRE and barcode sequences were separated by an 18 bp spacer 
sequence including ClaI and SalI restriction sites that were used to add a minimal 
promoter and EGFP reporter, and thereby position the CRE sequences upstream 
of the promoter and barcodes in the EGFP 3' UTR. 15 bp primer binding sites 
(Inoue, et al. 2017) were added at the ends of the oligos to yield 230bp oligo 
sequences. 
3.5.2 Cloning oligo library into lentiviral vector 
 A lentiviral reporter vector backbone was constructed from the pGPG 
lentiviral transfer plasmid provided by the UMass Worcester Viral Vector Core. 
The CMV promoter within pGPG was removed by ClaI and XbaI digestion. A 
minimal promoter from pGL4.23 was was PCR amplified with primers adding ClaI 
and XbaI restriction sites. This minimal promoter was ClaI- and XbaI-digested 
and cloned into pGPG to produce the reporter backbone pGPG_mP. The vector 
was digested with ClaI and SalI, and the minimal promoter-EGFP fragment and 
the linear pGPG backbone were gel-purified. 
 Array synthesized oligos were run on a 10% TBE-Urea denaturing 
polyacrylamide gel, stained with SYBR Gold, and 230-mer bands were excised 
and resuspended in TE Buffer. Gel-purified oligos were amplified with emulsion 
PCR to add vector-complementary tails that abolish ClaI and SalI sites. Oligos 
were inserted into the linear pGPG backbone with Gibson assembly to produce 
the library pCRE. The pCRE library was ClaI and SalI digested and the 
previously excised minimal promoter-EGFP fragment was reintroduced by sticky 
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end ligation to produce library pMPRA. Both libraries, pCRE and pMPRA, were 
sequenced on an Illumina MiSeq to assess oligo quality and library diversity. 
3.5.3 Library Sequencing 
 Library pCRE was sequenced on an Illumina MiSeq using 2 x 250 bp 
paired-end reads to assess library quality. Illumina adapter sequences and 
custom read primers (Supplementary Table 3.5) were added to CRE-barcode 
sequences in the pCRE library using emulsion PCR with primers pCRE_adpt_F/ 
R to bind 15 bp sites at the ends of the designed oligos (Supplementary Table 
3.5). A total of 8.5 million paired-end reads were generated. 91% of the designed 
oligos were present in the pCRE library and 72% of designed oligos have at least 
one perfect match. 
 Library pMPRA was sequenced on an Illumina MiSeq using 300 bp single-
end reads to assess oligo abundance in the final library. CRE regions were 
amplified with primers pMPRA_QC_F/ R (Supplementary Table 3.5) that bind 
opposite sides of the CRE insert. Amplicons were prepared for Illumina 
sequencing with NEBNext Ultra II DNA Library Prep Kit (NEB, E7645) and 
sequenced using standard Illumina primers. A total of 31 million reads were 
generated for 12,777 unique oligos, representing ~77% of the designed library.  
3.5.4 Cell Culture and Transduction 
 Neural progenitor cells (NPCs) and neurons were differentiated from 
induced pluripotent stem cells (iPSCs) that were from the Gilad lab at the 
University of Chicago. In total, six iPSC lines, three human and three 
chimpanzee (Supplementary Table 3.6), were used to produce NPCs and 
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neurons. iPSCs were initially cultured in mTeSR1 medium (STEMCELL 
Technologies), and were subsequently cultured in Neural Induction Medium for 
~3 weeks to produce NPCs. Neurons were differentiated from NPCs by culturing 
for one week in neural differentiation medium (STEMCELL Technologies), and 
one week in neural maturation medium (STEMCELL Technologies). NPCs and 
neurons of each cell line were cultured in triplicate in 6-well plates until cells were 
~90% confluent. Library pMPRA, packaged into lentiviral particles by the UMass 
Worcester Viral Vector Core, was used to transduce cells at a multiplicity of 
infection of 10 by replacing medium for medium containing virus. Medium was 
removed and replaced 24 hours after infection. Cells were washed, trypsinized, 
and collected by centrifugation 48 hours after infection.  
3.5.5 RNA and DNA Library Preparation and Sequencing 
 Total RNA and DNA were collected from each replicate with a Qiagen 
AllPrep kit (Cat 80204). NPC cell pellets were lysed by vortexing in buffer RLT 
with β-mercaptoethanol. Neuron cell pellets were lysed in a TissueLyser II at 
30Hz for 1 minute in buffer RLT with β-mercaptoethanol. cDNA was synthesized 
from 1500ng of total RNA from each replicate with SuperScript III (Invitrogen) 
using random primers. PCR to amplify barcodes from DNA and cDNA was 
carried out using NEB Phusion polymerase and primers MPRA_seq_F&R 
(Supplementary Table 3.5): 98C for 30 sec, 25 cycles of (98C for 10 sec, 63C for 
30 sec,  and 72C for 10 sec), and 72C for 5 min. Two 25 ul reactions were 
performed for each replicate and PCR amplification of barcodes was performed 
separately for each each set of replicates from each cell line to avoid cross-
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contamination between samples. Following amplification, replicates were pooled, 
size-selected, and purified with AmpureXP beads (Beckman-Coulter). Libraries 
for Illumina sequencing were prepared with 250 ng of barcode amplicons using 
NEBNext Ultra II DNA Library Prep Kit (NEB, E7645). Sequencing was 
performed on an Illumina NextSeq to generate 2 x 150bp overlapping paired-end 
reads. Libraries from NPCs and neurons were sequenced in separate assays. To 
obtain higher read coverage in cDNA libraries 50% more cDNA than DNA was 
added to the pool. In total, we obtained 67M reads for NPCs and 77M reads for 
neurons. 
3.5.6 Assessing CRE Activity 
 To obtain counts for RNA and DNA from each CRE, we began by merging 
forward and reverse read pairs with NGmerge (Gaspar 2018). We counted 
barcodes from reads if the barcode sequence and 3 adjacent base pairs on both 
sides matched the designed sequence exactly. We further filtered reads to 
include only those with q values 14 or greater (p-value < 0.05) for every base in 
the barcode. Within each replicate we counted the occurrence of each oligo from 
the RNA and DNA reads. We only kept RNA reads if DNA for the same oligo was 
sequenced in the same replicate. The sum of RNA and DNA counts was 
calculated for all oligos tiled across each CRE for each replicate. To account for 
different sequencing depth between replicates we calculated counts per million 
for RNA and DNA counts and then calculated the ratio of RNA to DNA for each 
CRE. There were 1157 orthologous CRE pairs tested in the assay, and we 
counted CREs as active if they were expressed in at least 2 replicates of either 
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species cell type. 268 CREs passed this filter and were used for differential 
expression analysis. To assess activity between orthologs we used limma 
(Ritchie, et al. 2015) to test for significant differences in expression across all 12 
biological replicates for human and chimpanzee CREs and found 179 DE CREs; 
100 with higher expression from the human ortholog, and 79 with higher 
expression from the chimpanzee ortholog. Differences in expression between 
neurons and NPCs was tested separately for human CREs and chimpanzee 
CREs by comparing expression across all 6 biological replicates of each cell 
type. 
3.5.7 Selection Testing 
 We tested CREs in our assay for signs of positive selection using the 
method described by Haygood et al. (2007). This test uses CRE sequence 
alignments (or any non-coding sequence) to determine nucleotide substitution 
rates in a specific sequence and then uses a another sequence alignment of 
intergenic and intronic regions within 100kb of the test sequence and determines 
a neutral substitution rate. If the substitution rate in the CRE sequence is higher 
than in the neutral sequence, positive selection is inferred. The code to execute 
this script is available on GitHub 
(https://github.com/ofedrigo/TestForPositiveSelection) and is executable in 
HyPhy (Pond, et al. 2005). 
3.5.8 CRE-gene assignments and gene ontology analysis 
 In order to explore putative functions of CREs, we assigned CREs to 
genes using GREAT (McLean, et al. 2010) with the "basal plus extension" 
 
 84 
method, including curated regulatory domains. This method defines regulatory 
domains for genes and assigns these genes and their annotations to CREs that 
fall within the defined regulatory domains. For selected sets of CREs (all, tested, 
active, DE, and selection CREs) we used the GREAT-associated genes to 
perform functional enrichment analysis for gene ontology biological processes 
using gProfiler (Raudvere, et al. 2019). We used gProfiler's g:SCS algorithm that 
adjusts p-values for multiple testing to assign a significance threshold (q-value) of 
0.05 to category enrichments. Enriched GO terms were grouped into similar 
parent categories (e.g. cell-cell signaling, adhesion, regulation of transcription, 
etc.) based on term names (Figure 3.2B). Semantic similarity measures were 
calculated with GOSemSim (Yu, et al. 2010) using the enriched Term IDs output 
from gProfiler. 
3.5.9 Assessing genomic distribution of CREs 
 To compare the gene density in proximity to CREs, we counted TSSs 
within 1Mb of either the 5' or 3' end of CREs. Ensembl-annotated TSS data were 
obtained from the GRCh38 dataset in Biomart (Zerbino, et al. 2018). To assess 
the number of putative enhancers within 1Mb of either the 5' or 3' end of CREs, 
we used H3K27ac and H3K4me2 ChIP-seq data human embryonic cortex 
(Reilly, et al. 2015) and H3K27ac ChIP-seq data from adult human brain 
(Vermunt, et al. 2014). From the Reilly et al. (2015) dataset, we only chose 
sequences that had both acetylation and methylation marks in the same replicate 
at any time point. From the Vermunt et al. (2014) dataset, we chose sequences 
with acetylation marks in at least two biological replicates from any of the brain 
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regions tested. To compare the size of the regulatory domains that contain the 
CREs in our assay, we used the same Reilly et al. (2015) and Vermunt et al. 
(2014) datasets and used the bedtools intersect command to look for overlap 
between CREs in our assay and functional regulatory domains. 
3.5.10 Assessing GC content and CpG motif abundance 
 We calculated the GC content and CpG motif abundance in all CREs in 
our assay by directly analyzing the sequences of our CREs. We obtained CRE 
sequences from the hg38 genome downloaded from the UCSC table browser 
(Karolchik, et al. 2004) and directly counted the occurrences of C and G 
nucleotides and CpG dinucleotides to determine their abundance. 
3.5.11 TF motif identification and comparison between species 
 To look for TF motifs, we scanned human and chimpanzee CREs for the 
presence of 579 experimentally defined transcription factor binding sites 
described in the JASPAR CORE Vertebrate database (Khan, et al. 2018). We 
looked for these motifs with the FIMO package from the MEME suite (Grant, et 
al. 2011) using sequences for all human or chimpanzee CREs as background 
when scanning for motifs in either species, and used a p-value threshold of 10-4. 
To determine if TF motifs are more enriched in CREs than other non-coding 
regions, we scanned a random set of 1000 human and chimpanzee intergenic or 
intronic sequences for JASPAR motifs using the same parameters as our scan in 
CRE sequences. Random sequences were chosen by collecting all intergenic 
and intronic regions, excluding first introns, removing sequences less than 500 
bp, and taking only the first 5000 bp of longer sequences. 
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 To look at how motifs are changing between species, we counted the total 
number of occurrences of each motif for each species within each CRE set and 
then calculated the fold-change in motif frequency between species. This 
comparison of motif frequency across all background CREs provides the global 
frequency change between species. This same comparison in selection or DE 
CREs, however, will also show motif differences that are due to global motif 
frequency differences between species. To account for this, we calculated the 
difference in between-species motif fold-change between selection or DE CREs 
and background CREs. Then, to identify the motifs that have more changes 
between species in CRE subsets than background, we chose motifs for which 
the difference between selection or DE CREs and background CREs was > 2 
standard deviations from the mean difference. 
3.5.12 Associating CREs with GWAS SNPs and visualizing chromatin 
contacts 
 SNPs associated with neuropsychiatric diseases were obtained from the 
NHGRI-EBI GWAS catalog (Buniello, et al. 2019) by searching disease terms for 
Alzheimer's disease, autism, attention deficit hyperactivity disorder, bipolar 
disorder, major depressive disorder, or schizophrenia. To identify SNPs and 
CREs that occur in the same loci, we assigned each to nearby genes using 
GREAT (McLean, et al. 2010) with the "basal plus extension" method, including 
curated regulatory domains. We then intersected the genes associated with 
SNPs and CREs to find loci that contain GWAS variants and putative regulatory 
elements. To visualize genomic contacts within GWAS loci we used Hi-C data 
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(Schmitt, et al. 2016) from human prefrontal cortex, which were downloaded from 
the 3D Genome Browser (Wang, et al. 2018). The downloaded images included 
schematics of gene locations within these loci. These annotations were 
condensed to optimize space in the figure and unannotated transcripts were 
removed. 
3.5.13 Associating CREs with genes in the Wnt signaling pathway 
 To explore the regulatory regions that could be impacting genes in the 
Wnt pathway we first collected a set of genes associated with canonical Wnt 
signaling. We included all genes that were part of the "wnt signaling," "GO 
canonical Wnt signaling pathway," and "KEGG Wnt signaling pathway" gene sets 
in mSigDB (Subramanian, et al. 2005). We then checked if any of the CREs in 
our assay were located within 500kb of the TSSs of Wnt pathway genes.  
 We used to the following references to annotate interactions in the Wnt 
signaling pathway described in Figure 3.6. (Liu, et al. 2005) (Shang, et al. 2017) 
(Li, et al. 2012) (Sinner, et al. 2007) (Varelas, et al. 2010) (Posokhova, et al. 
2015) (Davidson and Niehrs 2010) (Yamamoto, et al. 2008) (Kizil, et al. 2014) 
(Dema, et al. 2016) (Pangon, et al. 2016) (Strovel, et al. 2000) (Kim, et al. 2013) 
(Dayma, et al. 2012) (Ramakrishnan, et al. 2018) 
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Table 3.1. Wnt pathway genes associated with multiple CRE 
expression or selection profiles. Some genes in the wnt signaling 
pathway were associated with multiple CREs or paralogous gens were 
associated with different CREs.CREs with signs of selection are 
indicated (sel), differential expression between orthologs (human or 
chimpanzee higher), and differential expression between cell types 







A  CRE Sources 
B Library Construction 
C Reporter Assay 
3 human NPC cell lines 
3 human neuron cells lines 
3 chimpanzee NPC cell lines 
3 chimpanzee neuron cell lines 
Sequence barcodes from RNA and DNA 















Figure 3.1. MPRA overview. (A) Accelerated CREs were identified by 
computational methods that compare substitution rates in conserved non-
coding sequences to surrounding neutral regions. Brain CREs were identified 
by the presence of histone marks associated with enhancers in humans but 
not other primates (shown in figure), or histone marks for enhancers in cortex 
but not other brain regions. (B) 230-mer oligonucleotides containing CRE and 
barcode sequences were cloned into a lentiviral vector, a minimal promoter 
and EGFP reporter gene were inserted between CREs and barcodes, and 
plasmids were packaged in lentivirus particles. Lentivirus containing MPRA 
library was used to transduce human and chimpanzee NPCs and neurons. 
RNA and DNA were collected to assess abundance of transcribed barcodes 





Figure 3.2. Filtering active CREs and GO analysis. (A) Background CREs 
include all 2274 orthologous CREs in designed array. Selection tests identified 
722 with signs of selection in human sequences. Tested CREs were identified 
in > 1 replicate for each human and chimpanzee ortholog. Active CREs were 
expressed in > 2 replicates of either species cell type. DE CREs were 
differentially expressed between orthologs. (B) Heatmap of log2 normalized 
RNA/ DNA ratio for human CREs and chimpanzee CREs, each across a total 
of 12 replicates of NPC and neurons from each species. Red and blue vertical 
bars on the left side of the plot indicate CREs that show significantly different 
levels of expression between orthologous CREs. (C) Proportion of enriched 








background, tested, active, differentially expressed (DE), and selection (Sel) 
CREs. (D) Semantic similarity of enriched gene ontology terms between CRE 
subsets. 
Figure 3.3. Genomic characteristics of selection and DE CREs. (A) The 
number of TSSs located within 1MB of background, selection (Sel) and 
differentially expressed (DE) CREs. Boxplots show median (horizontal black 
bar), first and third quartiles (upper and lower limits of boxes), whiskers (1.5 
times the IQR, the third minus first quartile), and individual points (values 
beyond 1.5*IQR). (B) Number of active brain enhances within 1MB of CREs. 



















Figure 3.4. Activity versus transcription factor motif occurrences. 
The sum of log2-normalized RNA/DNA counts across all replicates is 
plotted against the total number of transcription factor motif 
occurrences in each CRE. Spearman correlation testes show 
relationships between motif occurrences and CRE activity. 
that contain CREs. (E) GC content in human and (F) chimpanzee CREs. (G) 
Plot of activity against size for human and chimpanzee CREs. Activity is the 
sum of log2-normalized RNA/DNA counts across all 12 replicates. Spearman 








Figure 3.5. Chromatin contact maps in GWAS loci. (A -D) Hi-C data 
generated from prefrontal cortex by Schmitt et al. (2016) showing 
chromatin contacts in loci containing GWAS SNPs and DE CREs at 
the marked locations. Chromatin contacts are shown at 40kb 
resolution (each individual square is 40kb). Gene annotations under 
each Hi-C map were part of the 3D genome browser (Wang et al. 
2018) visualization but do not include unannotated transcripts. (E) 
Table describing GWAS SNPs, traits, nearby genes, and CREs in 
each locus. Log2-normalized RNA/DNA counts are shown for 






Figure 3.6. Genes modulating canonical Wnt signaling associated with 
selection and DE CREs. CREs were associated with genes if they occur 
within 500kb of TSSs. Genes associated with selection CREs have square 
outlines. Genes associated with CREs that are DE between orthologs 
have red (higher in human) or blue (higher in chimpanzee) fill. Genes 
associated with CREs that are DE between cell types are marked with 
horizontal (higher in NPC) or vertical (higher in neuron) stripes, and stripe 
colors indicate if the human (red stripes) or chimpanzee (blue stripes) 
CRE was differentially expressed. The selection and DE profiles of CREs 
associated with paralogous genes are combined for each gene in the 
pathway but are separately defined in Table 3.1. Genes with circular 
outlines and white color are not associated with CREs in our assay but are 






CONCLUSIONS AND FUTURE DIRECTIONS 
4.1 Fibroblast serum challenge 
 In the fibroblast serum challenge study, we use the well-established gene 
expression response to serum in cultured fibroblasts and compared that between 
humans and chimpanzees to explore changes in gene expression and gene 
regulation. We used this assay for several reasons: 1) this experimental design 
hinges on a known differential phenotype that distinguishes humans and 
chimpanzees, susceptibility to epithelial cancers, 2) the phenotype in question is 
directly related to a molecular phenotype, a coordinated gene expression 
response to a serum, 3) characterization of the molecular phenotype, gene 
expression, is amenable to high-throughput genomic assays such as RNA-seq to 
characterize gene expression, and DNase-seq that can inform about open 
chromatin, 4) the experimental design uses cultured fibroblasts, a system that is 
accessible for testing both humans and chimpanzees. 
 This assay was originally defined in human fibroblasts, and in our assay it 
showed a very similar expression profile even though we performed the study 
with different cell lines and a different method for measuring gene expression, 
RNA-seq rather than microarrays. This shows that the assay is robust to 
experimental variation. What was novel about this experiment was our 
comparison with chimpanzee. The gene expression responses of both species 
were similar to the core serum response, but we found that humans had higher 
activity of genes in wound healing and cancer pathways; this observation was 
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enabled by our global method of characterizing gene expression. By looking at 
accessible chromatin, we gain insight into how putative gene regulatory regions 
respond together with gene expression. We did find that there were differences in 
the response between species, namely more regions of chromatin opening in 
human than in chimpanzee. Explaining the relationship between open chromatin 
and gene expression is notoriously challenging, and we found the activity of DHS 
sites only explains about 25% of gene expression. While this is a weak 
correlation, this is not unexpected given that regulatory regions act on genes 
beyond those that are most proximal, and that multiple regulatory sites control 
the expression of a single gene.  
4.2 Functional characterization of cis-regulatory elements 
 Our functional characterization of cis-regulatory elements focused on 
enhancers that have roles in neural development or adult neural function. We 
used a unique approach to curate a set of CREs to test in this assay, choosing 
both conserved non-coding sequences that have accelerated substitution rates in 
humans, and regulatory elements that are active in developing or adult human 
brain. This approach differentiates our study from others in that we use a broad 
set of enhancers instead of focusing on regions that only have one specific type 
of enhancer characteristic. We tested the function of orthologous human and 
chimpanzee sequences, identified evolutionary changes in these sequences, 
used a relevant physiological context, neural progenitor cells and neurons, that 




 With this assay we were able to find enhancers that fall broadly into two 
distinct sets: enhancers that have signs of positive selection and generally do not 
have significant differences in activity between human and chimpanzee 
sequences, and another set that show dramatic differences in activity between 
human and chimpanzee sequences but generally do not have signs of positive 
selection. This separation comes largely from our experimental design that tests 
developmental enhancers experiencing positive selection in humans and a set of 
active brain enhancers. It is not surprising that most developmental enhancers do 
not show dramatic differences in activity between orthologous sequences. In 
general these sequences are highly conserved among mammals, which also 
suggests functional conservation; this inference is supported by our 
measurements of enhancer activity. We found an abundance of enhancers under 
positive selection around the Wnt signaling pathway that has roles in body plan 
patterning and cell fate specification suggesting that adaptive changes in human 
enhancers act on highly conserved pathways, but in general the changes in 
activity are subtle. Large changes in Wnt signaling could be detrimental during 
development, but some differences in activity can be adaptive if they occur in 
define spatiotemporal contexts.  
 Many enhancers with significant differences in activity between orthologs 
are located in loci with genetic variants associated with neuropsychiatric 
diseases. These variants are located in non-coding regions and thus impact 
phenotypes through the regulation of gene expression rather than changing 
protein coding sequences. This shows that variation between humans in 
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processes affected by evolutionary changes in gene regulation can have impacts 
on cognitive and behavioral phenotypes. This helps us understand increased 
human susceptibility to neuropsychiatric diseases; natural variation in the human 
population on top of already adaptive changes to cognition and behavior extends 
the spectrum of observed phenotypes to include unique phenotypes that we 
characterize as abnormal, or disease states. A better understanding of the 
developmental changes that lead to extreme phenotypes can provide directions 
towards novel therapeutic approaches. 
4.3 Future Directions 
 The experiments described in this thesis help bridge the gap between 
unique physiological phenotypes and the underlying genomic changes that have 
occurred in human evolution. Finding experimental systems to investigate these 
differences in a controlled way can be challenging, but advances, especially in 
the field of stem cell biology, give the opportunity to study between-species 
differences in well-defined physiological contexts. Here we used NPCs and 
neurons that were differentiated from iPSCs, but otherwise would be difficult cell 
types to isolate. From these iPSCs our lab has already differentiated human and 
chimpanzee astrocytes, which are an abundant type of glial cell in the brain. 
There is evidence that astrocytes have roles in development, axon guidance, and 
engage in signaling with neurons (Sofroniew and Vinters 2010). Understanding 
the roles of the diverse cell types in the brain is an expanding field, and 
examining how regulatory function evolves in these cells can help us understand 
more about the unique processes that occur during human brain development. 
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The MPRA library that we've tested in NPCs and neurons is prepared in lentivirus 
and ready for use in other cell types, so testing the library in astrocytes is a 
feasible next step. 
 One of the benefits of the MPRA described here is the identification of a 
large number of differentially active enhancers. However, hits from high-
throughput screens should be validated in follow-up assays to confirm differential 
regulation between orthologs. Conventional reporter assays, for example 
luciferase assays, can help support the results we found in our study. 
Additionally, our data show differential activity in cells cultured in vitro. Examining 
the spatial and temporal aspects of this activity, however, can give insight into 
the developmental stages and specific tissue regions where enhancers are 
active. These experiments could be performed by creating transgenic mice that 
harbor a lacZ reporter constructs to enable visualization of expression patterns.  
 Additionally, linking candidate enhancers to their target genes is still a 
challenge since enhancers can act distally to their target genes. Layering 
external datasets such as Hi-C lets us look globally at where physical interactions 
occur, but the resolution of these experiments is low and physical interactions 
between distal regulatory regions and promoters could vary between cell types. 
For candidate loci, performing chromatin conformation capture (3C) experiments 
can help validate regulatory interactions. These experiments are best performed 
in regions where physical interactions are suspected because the experimental 
design tests association between a priori defined sequences. However, these are 
suitable experiments when investigating one or several candidate enhancers. In 
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our assay, for example, we saw a human enhancer that is highly expressed and 
located near the frizzled receptor FZD1. Validating the activity of that enhancer 
and testing physical interaction with the FZD1 promoter would provide good 
evidence that this enhancer is controlling frizzled expression. 
4.4 Closing Remarks 
 Understanding the molecular mechanisms driving human phenotypes 
remains one of the major challenges in modern biology. The work described in 
this thesis furthers our understanding of two traits in particular: the gene 
expression programs that occur in the wound healing response that is associated 
with increased susceptibility to epithelial cancers and the developmental and 
regulatory programs that give rise to our highly complex brains and increased 
cognitive capacity. Using evolutionary genomic approaches to studying these 
phenomena allows us to identify uniquely human aspects of physiology that help 
inform about the adaptive changes that make us human and the variation in 
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